NAME:
Saeed R. Khan
ADDRESS:
Department of Pathology
College of Medicine, Box 100275
University of Florida
Gainesville, Florida 32610
UNIVERSITY EDUCATION:
B.Sc.
1962
Agra University, Agra, India
M.Sc.
1964
Peshawar University, Peshawar, Pakistan
Ph.D.
1973
University of Florida, Gainesville, Florida
CONTINUING EDUCATION:
5.
American Urological Association Summer Research Conference, Houston, Texas, August 1012, 2001
4.
Workshop on Molecular Approaches to Kidney and Urologic Problems, Sponsored by
NIH/NIDDK, October 19-21, 1990
3.
Workshop on Scanning Tunnelling Microscopy, given by Dr. Phillip E. Russell of
Materials Science and Engineering Department Center, North Carolina State University,
during VIth Annual Meeting of the Florida Society for Electron Microscopy, 1988.
2.
Scanning Electron Microscopy and X-ray Microanalysis: Theory and Practice in Biology
and Medicine, State University of New York, New Paltz, New York, 1982.
1.
Vertebrate Cell and Organ Culture, The W. Alton Jones Cell Science Center, Lake Placid,
New York, 1980.
1
PROFESSIONAL EXPERIENCE:
2011
2012
Adjunct Professor, Department of Pathology
Finlayson Professor of Urological Research, Department of Urology
1997-2010
Professor
Department of Pathology,
1991
Associate Professor
Department of Pathology
1987
Assistant Professor
Department of Pathology
1985
Associate Research Scientist
Department of Pathology,
1982
Assistant Research Scientist
Department of Surgery/Urology,
1979
Assistant in Surgery
Department of Surgery/Urology
1978
Postdoctoral Fellow
Department of Pathology
1976
Assistant Professor
Biology Department
King Abdulaziz University
Jeddah, Saudi Arabia
1974
University Research Fellow
Plant Pathology Department
University of Adelaide,
Adelaide, Australia
1973
Assistant Professor
Institute of Biological Sciences
Islamabad University, Islamabad, Pakistan
1964
Lecturer in Biology, Directorate of
Education, NWFP Region,
Peshawar, Pakistan
2
TEACHING EXPERIENCE:
2006-2010
Lecturer, Special Topics in Pathology, Cellular and Molecular Basis of
Kidney Diseases
2004, 06
Coordinator, Special Topics in Pathology, Cellular and Molecular Basis
of Kidney Diseases
1991-02
Mechanisms of Disease
Coordinator and Lecturer
Graduate Course
1989-95
Systemic Pathology III,
(Medical Students)
1989
Special Topics in Pathology,
Graduate Course
1989
Workshop on "Biological X-ray
Microanalysis" to Members of Florida
Society for Electron Microscopy,
1988
Biology and Taxonomy of Ascomycetes
& Their Imperfect Stages, and Lichens,
Graduate Course
1973,74
Cell Biology
Graduate Course
1973,74
Mycology
Graduate Course
1972
Electron Microscopy and Cytochemistry,
Teaching Assistant
1964-70
Undergraduate General Biology
Undergraduate Botany
GRADUATE COMMITTEE ACTIVITIES
Department of Pathology and Laboratory Medicine
3
Doctoral Dissertation
Chairman
Jayashree A. Gokhale,
Joanne Johnson-Tardieu,
Member
Liliana Guedez
1995
Ying Yu
Christy Myrick
1995
Brian E. Szente
Michael Ambrose
Lucia Fernandes Aleixo1996
1995
1998
1995
1993
1993
Masters Thesis:
Chairman
Suzanne A. Maslamani
Julie M. Norton-Fasano
Marie E. Buie
1998
1999
2001
Member
Monique Y. Huggins,
Xin (Cindy) Zhang,
Xianggao Ye,
1995
1995
1994
Department of Pharmaceutics
Member
Vikram Arya,
2003
Sassiporn Sarawek
2007
Kai Wu
2006
Pattaraporn Vanachayangkul 2008
Karin Haug
Current
Wan, Sun
Current
Department of Plant Pathology
Doctoral Dissertation
Member
Li-Tzu Li,
Chi-Guang Wu,
1994
1994
Department of Materials Science and Engineering
Doctoral Dissertation
Member
4
Richard V. Linhart,
Kimberly G. Christmas,
Fairland Amos
Saijit Daosukho
Farid Vaghefi
1994
2001
2005
2007
2012
Archana Chidambaram
current
Masters Thesis
Jin-Hwan Jeon,
Charley Malpass,
2002
2001
Department of Chemistry
Doctoral Dissertation
Member
Scott Whipps
Isa Benitez
Denise Sharbaugh
1996
2004
2010
RESEARCH FELLOWS:
Dr. Chung-Jen Su, M.d., Ph.D.
Dr. D. Ackermann, M.D.
Dr. D.J. Kok, Ph.D.
Dr. Fouad Atmani, Ph.D.
Dr. Sivagnanan Thamilselvan, Ph.D.
Dr. Shizuka Iida, M.D., Ph.D.
Dr. Manbu Moriyama, M.D., Ph.D.
Dr. Tohru Umekawa, M.D., Ph.D.
Dr. J. Y. Tsai, M.D., Ph.D.
Dr. Kinue Aihara, M.D., Ph.D.
Dr. Pouran Habibzadegah-Tari, Ph.D.
Dr. Carla Escobar, Ph.D.
Dr. Hassan Khaskhali, Ph.D.
Dr. Jian Zou Ph.D.
Dr. Benjamin K. Canales, M.S., M.D., current
Dr. Sunil Joshi, Ph.D., current
Dr. Hidenori Tsuji, M.D., Ph.D.
5
DEPARTMENTAL, COLLEGE AND UNIVERSITY ADMINISTRATION AND COMMITTEES:
2010
Member, Senate Infrastructure Policy Council
2009
Member, COM Mentoring Selection Committee
2007-08
Member, IDP M.S. Curriculum Committee
2007-10
Member, Faculty Senate
2007-08
Member, Senate Steering Committee
2007-08
Member, Research Policy Committee
2007-10
Member, Senate Academic Policy Council
2007-08
Chair, Senate Research and Scholarship Policy Council
2006-07
2006-07
Chair, Senate Honorary Degrees, Distinguished Alumnus Awards and
Memorial Committee
Member, Senate Research and Scholarship Policy Council
2006-07
Member, Senate Academic Policy Council
2005
Member, Animal Resources and Research Advisory Group
2005
Member, University of Florida Teacher/Scholar of the Year Award
Committee
2005
Member, Medical Student Research Program Committee
2004-07
Member, Senate Honorary Degrees Distinguished Alumnus Awards and
Memorial Committee
2004-08
Member, Senate Research and Scholarship Policy Council
2004-05
Chair, Senate Research and Scholarship Policy Council
2004-05
Member, UF Research Policy Council
2004-06
Member, University of Florida Faculty Senate
2004
Member, Medical Student Research Program Committee
6
2004
Member, Selection Comm for Doctoral Dissertation Advisor/Mentoring
Committee
2004
Member, Panel of Judges for Medical Student’s Research Presentations
2004
Member, Selection Comm Research & Graduate Programs Opportunity Fund
2003-05
Member, Graduate Coordinators Advisory Council
2003-06
Member, Faculty Senate Steering Committee
2000-2002
Member, University of Florida Faculty Senate
2000-
Member, Departmental Clinical Research Committee
1986-
Laboratory Host and Mentor, Annual Student Science Training Program
(SSTP), Center for Precollegiate Education and Training, University of Florida
1996-
Director, Center for the Study of Lithiasis and
Pathological Calcification
2000-02
Director, Research and Academic Affairs, Division of
Experimental Pathology, Department of Pathology
1998-02
Chief, Division of Experimental Pathology, Department of Pathology
2001
Member, Medical Student Research Committee
2001
Member, Oversight Committee, Medical Education Week
2000-01
Chairman, College Investment Fund (CIF) Grant Review Committee
2000-01
Member, UF Faculty Advisory Committee to Animal Care Services
1999-
Member, College of Medicine, Electron Microscopy Committee
1998-02
Member, University of Florida Senate
1997-
Member, Department of Pathology Variable Compensation
Plan
1997-
Member, Advisory Committee to the College of
Medicine Associate Dean for Graduate Education
7
1994-2000
Alternate Member, Institutional Review Board
2000
Member, Ad Hoc Committee, Professor’s Salary Increase
1998-01
Chairman, Immunology Faculty Search Committees
1999
Chairman, Selection Committee for College of Medicine
Faculty Council Excellence in Basic Science Research Awards
1999
Chairman, Medical Guild Graduate Student Research Competition
Committee
1999
Chairman, Selection Committee for University Scholar’s Program
1998-99
Member, Research Committee, Howard Hughes Medical Research Institute
Research Resources Program
1998-99
Chairman, Computer Operations Committee, Department of Pathology
1998
Member, Selection Committee for College of Medicine
Professional Excellence Program (PEP) Awards
1998
Member, Selection Committee for College of Medicine
Teaching Incentive Program (TIP) Awards
1998
Member, Surgical Pathology Faculty Search Committees
1997
Member, The PhD/MBA subcommittee
1997
Chairman, Selection Committee for College of Medicine
Faculty Council Excellence in Research Awards
1995
Member, College of Medicine Diversity Group
1994-98
Pathology Representative, College of Medicine
Faculty Council
1993-94
Director, Center for the Study of
Inflammatory Host Defense & Tissue Injury
1992-94
Director, Graduate Program, Department
of Pathology
1992-94
Member, Department of Pathology Section Chief's Committee
8
1991-94
Departmental Representative, Pathology
Comparative Pathology Joint Electron Microscopy Facility
1990-99
Member, Department of Pathology Graduate Committee
1989-90
Member, Advisory Committee to the Center for
International Student and Scholar Services
1989-90
Member, Shand’s Hospital Kidney Stone Center Committee
1989-90
Member, University of Florida Task Force on
International Students and Visiting Scholars
9
NATIONAL & INTERNATIONAL RESEARCH GRANT AND PROGRAM REVIEW AND ADVISORY
COMMITTEES:
2012,
Member, NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY
DISEASES, Member Conflict Telephone SEP, ZDK1 GRB-G (M2)
2009-2013
Member, NATIONAL INSTITUTES OF HEALTH, NATIONAL INSTITUTE OF
DIABETES AND DIGESTIVE AND KIDNEY DISEASES, SPECIAL EMPHASIS PANEL,
ZDK1 GRB-G M1 1, The NIDDK-KUH Fellowship Review Committee
2009
Reviewer, NIDDK, Challenge Grants, RFA-OD-09-003
2008
Reviewer, Joint Research Grant under National Research Foundation South
Africa/Japan Society for the Promotion of Science
2008
Member, NIDDK Special Emphasis Panel, ZDK1 GRB-6 01 1, George M.
O'Brien Urology Research Centers (P50), July 21-22
2008
Member, Urology Overflow Group, ZRG1 RUS-F (02) S, June 17, 2008
2008
Member, Dallas Kidney Stone Program Project Grant Review, ZDK1 GRB-7
(M2), April 10, 2008
2007
Member, Fellowship: Physiology and Pathobiology of Organ System, F10-H
20L, Study Section, March 2007
2006-10
Member, Urologic and Kidney Development and Genitourinary Diseases
(UKGD) Study Section
2006
Member, ZRG1 RUS-A 51 1, NIDDK PAR 06 113, October 26-31
2006
Reviewer, Research Grant Management, South African Medical Research
Council, Cape Town, South Africa
2006
Member, NIH Center for Scientific Review, ZRG1 EMNR-E (10),
Endocrinology, Metabolism, Nutrition and Reproductive Sciences, March 910, 2006
2006
External Referee, Innovational Research Incentives Scheme, Netherlands
Organization for Health Research and Development, Netherlands
2006
Consultant Reviewer, Health Research Board, Ireland
2005
Chair, NIDDK ZDK1 GRB-9 (J1), Special Emphasis Panel, Nephrolithiasis,
10
November 21, 2005
2004
Member, National Center for Complementary and Alternative Medicine
Special Emphasis Panel, ZAT1 DB15, Basic and Preclinal Research, June 7-8.
2003-05
Member, Scientific Review Board, Oxalosis and Hyperoxaluria Foundation,
St Louis, Missouri
2003
Consultant Reviewer, Reviewer, VA Merit Review Application, R. Tyler Miller,
Cleveland, Ohio
2002
Member, Center for Scientific Review Special Emphasis Panel, ZRG1 UROL
(01), July 9-10
2002
Member, Center for Scientific Review Special Emphasis Panel, ZRG1 UROL
(17), Small Business: Urology, July 10
2002
Assessor (Reviewer), Grant PolyU 5265/02M, Research Grants Council,
University Grants Committee, Hong Kong, China
2001
Member, Special Emphasis Panel CSR/NIH SSS-T-10B Study Section,
Endocrine and Reproductive Sciences and Nutritional and Metabolic
Sciences Integrated Review Groups, November 8
2001
Reviewer, Masters of Science Program in the Department of Pathology,
College of Medicine, Kuwait University, Kuwait, May 18-22rd 2001
2001
Reviewer, VA Merit Review Application, Dr. Neil S. Mandel, Professor of
Medicine, Biophysics, Biochemistry, Orthopedic Surgery, Medical College of
Wisconsin, Associate Dean for VA Research and Associate Chief of Staff for
research, Zablocki VA Medical Center, Milwaukee, Wisconsin.
2001
Reviewer, VA Merit Review Application, Dr. Jeff A. Wesson, Department of
Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin
2001
Assessor (Reviewer), Grant PolyU 5280/01M, Research Grants Council,
University Grants Committee, Hong Kong, China
2000
Reviewer, Travelling Research Fellowship Application, The Wellcome Trust
London, England
2000-04
Consultant, Program Project on Kidney Stones, University of Chicago,
Chicago
11
1999
Reviewer, Stone Grant, St. Peters Trust, London, England
1999
Member, Review Comm, National Institute of Diabetes and Digestive and
Kidney Diseases, RFA: DK-98-018 “Urology Research Centers”,
March 25-26, Baltimore, Maryland
1998
Reviewer, Kidney Stone Grant, The Division of Biology and Medicine,
Swiss National Science Foundation, Berne, Switzerland
1998
Member, National Institute of Diabetes and Digestive and Kidney Diseases
(NIDDK) Special Emphasis Panel Review Committee, University of Texas
Southwestern Medical Center Program Project Application, Formulation of
Rational Therapy of Nephrolithiasis (Dr. Charles Y.C. Pak, PI)
1996-1999
Member, National Institutes of Health (NIH)
Urology Special Emphasis Panel Study Section
1996-00
Member, Scientific Review Board, Oxalosis and Hyperoxaluria Foundation,
St Louis, Missouri
1995-97
Member, National Institutes of Health (NIH) General Medicine - B Study
Section
1995-1999
Member, Advisory Group, O’Brien Center on Kidney Stones, University of
Chicago, Chicago
1990-95
NIH, Ad-hoc Reviewer on Urinary Stone Grants
1990-91
Veteran’s Administration, Reviewer on Urinary Stone Grants
1990-92
Member, NIDDK Special Grants Review Committees, University of Chicago
Program Project Application, Pathogenesis and Treatment of Calcium
Nephrolithiasis (Dr. Frederic L. Coe, PI).
12
ORGANIZATIONAL EXPERIENCE:
2008-2012
Member, Scientific Advisory Board, 12th International Symposium on
Urolithiasis, May 9-12, 20012, Ouro Preto, Brazil
2007-08
Member, International Scientific Committee, World Congress of Nephrology
Satellite symposium, Bone, Stone and Kidney, April 26-28, Rio de Janeiro,
Brazil
2008-09
Member, Scientific Committee, 12th European Symposium on Urolithiasis,
October 15-17, Lake Como, Italy
2006-7
Member, Scientific Committee, 12th European Symposium on Urolithiasis,
July 4-7, 2007, Lisbon, Portugal
2004-08
Member, International Organizing Committee, International
Symposium on Urolithiasis, Niece, France, to be held 2008
2004
Member, International Advisory Committee, 7th International Workshop on
Primary Hyperoxaluria, October 8-10, Mayo Clinic, Rochester
2006
Chair, Nominating Committee, Society for Leukocyte Biology
2004-7
Member, Nominating Committee, Society for Leukocyte Biology
2004
Member, International Organizing Committee, International
Symposium on Urolithiasis, Hong Kong, May 24-28, 2004
2003-04
Member, Graduate Coordinators Advisory Council
2004-05
Chair, Faculty Senate Research and Scholarship Policy Council
2002-03
Chair, Faculty Senate Nominating Committee
2002-03
Chair, Faculty Academic Advisory Council
2000-2001
Past President, Faculty Council, College of Medicine
1999-00
President, Faculty Council, College of Medicine
1997-00
Member, International Organizing Committee, International
Symposium on Urolithiasis held February 13-17, 2000; Cape Town, South
Africa
13
1999
Organizer, 2nd Finlayson Colloquium on Urolithiasis,
January 28-31st, Gainesville, Florida
1998-99
President-elect, Faculty Council, College of Medicine
1997-99
President, Society for Research on Calculus Kinetics
(The ROCK society)
1997-98
Vice President, Faculty Council, College of Medicine
1993-95
Secretary-Treasurer, The ROCK society
1993-94
President, Florida Society for Microscopy
1992-93
President Elect, Florida Society for Microscopy
1989-90
Director-at-Large, Biological Sciences, Florida Society for Electron
Microscopy
1991
Member, Organizing Committee, Joint Meeting of Florida Society for
Electron Microscopy, Alabama Society for Electron Microscopy and
Southeastern Electron Microscopy Society Gainesville, April 1st - April 4th.
1990
Member, Organizing Committee, Finlayson Colloquium on Urolithiasis,
Held at University of Florida April 22-24
1985
Member, Local Arrangements Committee, Annual Meeting of the
Mycological Society of America.
1988-89
President, Florida Society for Electron Microscopy
1987-88
President Elect, Florida Society for Electron Microscopy
1986-87
Vice President, Florida Society for Electron Microscopy
1986
Vice-Chairman, Gordon Conference on Calcium Oxalate
1984-86,89-90,93
Faculty Advisor, Muslim Students Association, University of Florida
1984-1994
Member Organizing Committee, Symposium on Stones and Crystals
in Disease, Annual Meetings of the Scanning Microscopy
International
1973
Chairman, Council of International Organizations, University of
14
Florida
1972
President, International Club, University of Florida
1971
Secretary, International Club, University of Florida
1964-66
Coach, Cricket Team, Government College, D.I. Khan, Pakistan
1961
Secretary, Biological Association, Reza Degree College,
Rampur, India
15
EDITORIAL AND JOURNAL REVIEW EXPERIENCE:
2010-
Member, International Advisory Board, Kuwait Journal of Science and
Engineering, Academic Publication Council, University of Kuwait, Kuwait
2004-
Member, American Urological Association Urolithiasis
Abstract Review Team
2008
Member, American Society of Nephrology Mineral Metabolism
Abstract Review Team
2007-
Member, Editorial Board, Nephron Experimental Nephrology
2004-
Associate Editor, Urological Research
2003-04
Member, Editorial Board, Urological Research
2002-04
Managing Editor, Frontiers in Bioscience
2000
Co-Editor, Proceedings of the 9th International Symposium on Urolithiasis,
University of Cape Town, Rondebosch, Cape Town, South Africa
1999
Co-Guest Editor, Kidney Stones: Recent Research and Management
Concepts, J Eondourology 13 (9)
1999
Guest Editor, J Am Soc Nephrol Supplement 10, Proceedings of
The 2nd Finlayson Symposium
1997-2000
Member, Editorial Board
Journal of Urology, Investigative Urology Section,
1996
Guest Editor, Stones and Crystals, Scanning Microscopy 10 (2), 303-612
1995
Member, American Society of Nephrology Mineral Metabolism
Abstract Review Team
1984-98
Member, Editorial Board,
Scanning Microscopy
1994-
Member, Editorial Board,
Italian Journal of Mineral and Electrolyte Metabolism
1991
Guest Editor,
Proceedings of Finlayson Colloquium
16
Urolithiasis, Journal of Kidney Diseases,
Vol. 17, April 1991
1982-
Ad-hoc Reviewer
1. Journal of Urology,
2. Scanning Microscopy
3. Cell and Materials
4. Kidney International
5. American Journal of Physiology
6. Clinical Chemistry
7. J. Clinical Chemistry
8. J. Clinical Investigation
9. J. Crystal Growth
10. J. Nutritional Biochemistry
11. J. Endourology
12. J. Bone and Min Research
13. Protein Science
14. Urology
15. Nephrol, Dialysis, Transplantation
16. Am J Kid Diseases
17. J Am Soc Nephrol
18. Clin Chem & Lab Med
19. Planta Medica
20. Experimental Biology and Medicine
21. African Journal of Biotechnology
17
INVITED STATE OF THE ART AND PLENARY LECTURES:
77.
May 12, 2012, Stress Oxidative: Urolithiasis and Chronic Kidney Disease, 12th International
Symposium on Urolithiasis, Ouro Preto, Brazil
76.
May 11, 2012, Crystal and cells, a Review. 12th International Symposium on Urolithiasis,
Ouro Preto, Brazil
75.
May 9, 2012. Plenary Debate, Basic Science Research of the Past 25 years: Prognosis for
Stone Treatment - Promising, 12th International Symposium on Urolithiasis, Ouro Preto,
Brazil
74.
February 24-28, 2012, 27th Annual Meeting of the European Association of Urology, Paris,
France, Meeting of the EAU Section of Urolithiasis (EULIS): Urolithiasis - new insights in
pathophysiology - challenges in education - trends in treatment
73.
September 8, 2011, The association of stone disease with chronic kidney disease, diabetes
and hypertension, is oxidative stress a common link? 1st Metting of European Association
of Urology Section of Urolithiasis (EULIS), London, United Kingdom.
72.
September 7, 2011, Of Mice and men, what do animal model studies reveal about
pathogenesis of kidney stones? 1st Metting of European Association of Urology Section of
Urolithiasis (EULIS), London, United Kingdom.
71.
September 12, 2010, Hypertension and nephrolithiasis. 25 th Brazilian Nephrology Meeting,
Vitorai, Brazil.
70.
September 14, 2010, Reactive Oxygen species (oxidative stress) and calcium oxalate
nephrolithiasis. 25th Brazilian Nephrology Meeting, Vitorai, Brazil.
69.
July 21, 2010, Renal oxidative stress in stone disease, evidence from animal model and
tissue culture studies. Nephrology Research Conference, Medical College of Wisconsin,
Milwaukee, Wisconsin
68.
February 14, 2010, Genetic Basis of Renal Cellular Dysfunction and the Formation of Kidney
Stones, University of Florida Department of Urology, CME Seminar, Ponte Vedra, Florida
67.
December 3, 2009, Nephrocalcinosis in Animal Models with or without Stones, 3rd
International Urolithiasis Symposium and Indiana University School of Medicine,
Continuing Medical Education Seminar, Indianapolis, Indiana
66.
October 16, 2009, Crystal/Cell Interaction : Oxidative Stress and Nephrolithiasis, 6th
Eurolithiasis Society Symposium and 16th European Symposium on Urolithiasis, Como, Italy
18
65.
June 12, 2009, Herbal Medicines in the Management of Urolithiasis: Alternative or
Complementary? 7th Symposium, New Developments in Clinical Pharmacy and Clinical
Pharmacology; Stresa, Italy
64.
October 25, 2008, Cellular Dysfunction and kidney stones, SIUT 6th International
Symposium of Urology, Nephrology and Transplantation, Karachi, Pakistan
63.
October 24, 2008, Alternative medicine for kidney stones, SIUT 6th International
Symposium of Urology, Nephrology and Transplantation, Karachi, Pakistan
62.
September 4, 2008, Crystal-Cell interaction: Reactive oxygen species, oxidative stress and
nephrolithiasis, 11th International Symposium on Urolithiasis, Nice, France
61.
April 26, 2008, Crystal Induced Inflammation, 2nd Annual Urology Research Retreat, Urology
Department, College of Medicine, UF
60.
November 7, 2007, Calcium Oxalate Nephrolithiasis: Animal Models, Urology Grand
Rounds, Urology Department, College of Medicine, UF.
59.
October 5, 2007, Investigations of Nephrolithiasis: Animal Model Studies, Urology Grand
Rounds, University of Colorado Health Sciences Center, Denver, Colorado.
58.
Aug 25th, 2007, Calcium Oxalate/Calcium Phosphate Association in Kidney Stones, Results
of Experimental Studies, State of the Art Lecture, 17th Annual Meeting of the Japanese
Society on Urolithiasis Research, Kurume , Japan
57.
Aug 21st, 2007, Hypercalciuric Mice, Special Lecture, Urolithiasis Mini-Forum, Kanazawa
Medical University, Uchinada, Ishikawa, Japan
56.
July 6th, 2007, What did we learn yesterday? Highlights of Presentations, 5th eUlis
Symposium, Lisbon, Portugal
55.
July 6th, 2007, Research Methods on Stone Disease, Round Table on Research Methods, 5th
eUlis Symposium, Lisbon, Portugal
54.
April 28, 2007, Invited Lecture, Crystal Attachment and Stone Formation, Bone, Stone and
the Kidney, World Congress of Nephrology Satellite Symposium, Rio de Janeiro, Brazil.
53.
May 26, 2006, Invited Lecture, Role of Injury and Inflammation in Urolithiasis, ROCK
Society Meeting at the Annual American Urological Association Meeting IN Atlanta.
52.
April 12, 2006, Surgical Grand Rounds, Agha Khan University Medical College, Karachi,
Pakistan
19
51.
April 10, 2006, Guest Lecture, Cell Injury/Dysfunction Critical for Stone Formation, Sindh
Institute of Urology and Transplantation, Dow Medical College, Karachi, Pakistan
50.
April 6, 2006, Visiting Professor, Renal Tubular Damage/Dysfunction Key to the Formation
of Kidney Stones, International Center for Chemical Scineces, University of Karachi,
Pakistan
49.
April 1, 2006, Seminar, Kidney Stone Microstructure, Studies of Biological Sciences,
University of the Punjab, Lahore, Pakistan
48.
March 28, 2006, Visiting Professor, Micromorphology of Kidney Stones, International
Center for Chemical Scineces, University of Karachi, Pakistan
47.
July 19th, 2005, State of the Art Lecture, Tissue injury induced by oxalate. FASEB Summer
Research Conference, Calcium Oxalate in Biological Systems, Tucson, Arizona
46.
June 16th, 2005, Discussant, Debate: The key to Stone formation is, Renal tubular
dysfunction. 11th European Urolithiasis Symposium, Coburg, Germany.
45.
February 25, 2005, Keynote Address, Urolithiasis Research – Past, Present and Future. SIUT
(Sind Institute of Urology and Transplantation) Urolithiasis Symposium, Karachi University,
Pakistan
44.
February 25, 2005, Plenary Lecture, Crystal-induced renal inflammation. SIUT Urolithiasis
Symposium, Karachi University, Pakistan
43.
February 26, 2005, Plenary Lecture, Animal Models of CaOx nephrolithiasis. SIUT
Urolithiasis Symposium, Karachi University, Pakistan
42.
October 8, 2004, State of the Art Lecture, Oxalate-induced oxidative stress in the kidneys,
7th International Workshop on Primary Hyperoxaluria, Mayo Clinic, Rochester, MN
41.
July 8, 2004, State of the Art Lecture Animal Models Calcium Oxalate Nephrolithiasis. I
xion Biotechnology, Alachua, Florida
40.
May 28, 2004, State of the Art Lecture, Animal Models of the Calcium Oxalate
Nephrolithiasis. 10th International Symposium on Urolithiasis, Hong Kong, May 25-28,
39.
December 1-15, 2003, Visiting Professor, Sindh Institute of Urology and Transplantation,
Dow Medical College, Karachi, Pakistan
38.
November 20, 2003, Plenary Lecture, Mediators of Oxalate Induced Tissue Injury, Oxalosis
and Hyperoxaluria Meeting sponsored by National Institutes of Health, Annapolis,
Maryland
20
37.
October 24, 2003, Invited Lecture, Crystal Cell Interaction: Cellular Involvement in Stone
Disease, Department of Urology, Nagoya City University, Nagoya, Japan
36.
October 24, 2003, Keynote Address Special Lecture, Crystal-Induced Inflammation of the
Kidneys: Results from Tissue Culture and Animal Model Studies, 33 rd Western Regional
Meeting of the Japanese Society of Nephrology, Nagoya, Japan.
35.
June 11, 2003, State of the Art Lecture, Organic Matrix of Kidney Stones: Its role in the
pathogenesis of urolithiasis, 10th European Symposium on Urolithiasis, Istanbul, June 11-14
34.
June 11, 2003, State of the Art Lecture, Crystal Cell Interaction: Cellular involvement in
stone disease, 10th European Symposium on Urolithiasis, Istanbul, June 11-14
33.
June 12, 2003, State of the Art Lecture, Stone research on the bench: where we are and
where we are going?, 10th European Symposium on Urolithiasis, Istanbul, June 11-14
32.
June 14, 2003, Take Home Message, Pathophysiology / Etiology, 10th European
Symposium on Urolithiasis, Istanbul, June 11-14
31.
May 28, 2002, First Annual Birdwell Finalyson Memorial Lecture, ROCK Society meeting at
the annual meeting of the American Urological Association, Orlando, Florida, , Stone
Research on the Bench: where we are and where we are going”
30.
April 5-6, 2002, Invited Lecture, 6th European Workshop on Hyperoxaluria, Hannover,
Germany.
29.
July 3-5, 2001, Member, Biochemistry of Stone Disease Committee, 1st International
Consultation on Stone Disease, Organized by Am Urol Assoc, Con Am Urol, Eur Assoc Urol,
Urol Asssc Asia, Soc Endourol, WHO, Intl Consul Urol Dis, Intl Soc Urol, Palais des Congress,
Paris, France.
28.
April 28th-29th , 2001, 4th Biennial Conference of Pakistan Society of Nephrology, Avari
Hotel, Lahore, Pakistan.
State of the Art Lecture: New Trends in Renal Stone Research
27.
April 10th -14th , 2001, 1st International and 11th National Chemistry Conference, Peshawar
University, Peshawar, Pakistan
Plenary Lecture: Nucleation of Calcium Oxalate
26.
November 16-17, 2000, Oxalosis and Calcium Oxalate Stone Disease, Workshop organized
by National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH.
21
State of the Art Invited Presentation: Animal Model of Hyperoxaluria, Experimental
Induction
25.
February 17, 2000, Invited Overview lecture, Crystal-cell Interaction,
The backbone of stone formation, Urolithiasis 2000, 9th International Symposium
on Urolithiasis, Cape Town, South Africa.
24.
November 30, 1999, Symposium on Mineralization in Natural and Synthetic Biomaterials,
Fall Meeting of the Materials Research Society, Boston, Mass.
Invited Lecture: Involvement of Cellular Membranes and Their Lipids in Nucleation of
Stone Forming Crystals.
23.
November 29, 1999, Department of Physiology, University of Massachusetts College of
Medicine, Worcester, Mass.
Seminar: Renal Epithelial Injury and Nephrolithiasis
22.
August 18, 1999, FASEB Summer Research Conference, Calcium Oxalate in
Biological Systems, Copper Mountain, Colorado
Invited Lecture: Cell culture and animal models in the study of nephrolithiasis
21.
June 9-12, 1999, 8th European Symposium on Urolithiasis, Parma, Italy
State of the Art Lecture: Calcium Oxalate Stone Formation as an Example of
Biomineralization
20.
May 28-29, 1999, 1st Istanbul Urolithiasis Symposium, Istanbul, Turkey
State of the Art Lectures
1. Inhibitors and Promoters of Stone Growth
2. Calcium Oxalate Crystals are Injurious to renal Epithelial Cells: Results of Studies in
Rat Model of Hyperoxaluria
19.
April 12-15, 1999, Keynote Address, 87th Annual Meeting of the Japanese Urological
Association, Osaka, Japan
Pathogenesis of Urolithiasis: Results of Experimental Studies
18.
March 12-13, 1999, 5th Workshop on Primary Hyperoxaluria, Kappel, Switzerland
22
Renal Epithelial Cells are Provoked by Exposure to both Oxalate and Calcium Oxalate
Crystals: Results of studies in a rat model of nephrolithiasis
17.
December 8-9, 1998, Workshop on New Horizons in the Pathogenesis,
Treatment & Cure of Hyperoxaluria, Oxalosis & Oxalate Stone Diseases, Sponsored by The
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda,
Maryland
State of the Art Lecture, Oxalate and Calcium Oxalate Crystals Provoke Renal Epithelial
Cells: Results of Studies in rat Models
16.
August 29, 1998, Keynote Address Special Lecture, Annual Meeting of the Urological
Association of the Republic of China, Taipei, Taiwan
Oxalate Induced Responses of Renal Epithelial Cells
15.
April 13, 1998, Hospital For Special Surgery, New York,
Metabolic Bone Disease Conference
Seminar: Crystal Cell Interaction and Calcium Oxalate Nephrolithiasis
14.
January 27, 1997,
MARC/MBRS Guest Lecture Series,
School of Natural and Health Sciences, Barry University, Barry University,Miami
Seminar: “Kidney Stone Formation”
13.
November 21, 1996. NIDDK, The Division of Kidney, Urologic and Hematologic
Diseases, NIH Campus, Bethesda, Maryland
Seminar: Calcium Oxalate Crystal-Renal Epithelial Cell Interaction and Kidney Stone
Formation
12.
June 8-10, 1995. Sixth European Symposium on Urolithiasis, Stockholm, Sweden
Invited Speaker Round Table Discussion
“What happens in the nephron in calcium oxalate stone disease”
11.
August 21-26, 1994, Mineral Scale Formation and Inhibition, Symposium in honor of
Prof. George H. Nancollas, American Chemical Society Meeting, Washington, D.C.
Invited Speaker,
“Role of Calcium Phosphate in Calcium Oxalate Crystallization in vivo”
10.
April 21st-23rd, 1994, 5th European Urolithiasis Symposium, Manchester, England
23
Invited Speaker Round Table Discussions on:
1. Methods of Crystallization Studies
2. Site and Mechanism of Stone Initiation
9.
October 4-5, 1993, Urolithiasis: State of the art and future research needs, Sponsored by
the Division of Kidney, Urologic and Hematologic Diseases, National Institute of Diabetes
and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland
State of the Art: Basic research
8.
December 27-29, 1993, 7th National Conference of Urolithiasis Society of India,
Madras, India
Keynote Address Oration Lecture: "Nephrolithiasis: A free or fixed particle disease."
7.
April 14, 1993, Symposium on hydroxyapatite and related materials, Spring meeting of
Materials Research Society, San Francisco
Title: Pathological Crystallization of calcium oxalate and calcium phosphate."
6.
April 1-3, 1993, 4th European Symposium on Urolithiasis, Tubingen, Germany
Title: "Cellular membranes as heterogeneous nucleator of calcium oxalate crystals."
5.
April 5, 1993, University Hospital, Marburg, Germany
Title: "Formation and retention of calcium oxalate crystals in the renal tubules."
4.
March 31, 1993, Faculty of Medicine and University Policlinic, Inselspital, Berne,
Switzerland
Title: "Formation and retention of calcium oxalate crystals in the renal tubules."
3.
August 23-27, 1992, 7th International Symposium on Urolithiasis, Cairns, Australia
Co-chairperson, Theme Poster Session on "Stone Composition: Matrix and Membranes."
Plenary Lecture: "Renal epithelial injury: a risk factor in urolithiasis."
2.
April 30th, 1992, Symposium on Pathogenesis, diagnosis and therapy of nephrolithiasis,
Ospedale S. Maria della Misericordia, Udine, Italy
Title: "Ultrastructural morphology of calcium oxalate crystal deposition in kidneys."
1.
October 18, 1991, Department of Nephrology, Institute of Internal Medicine and
24
Institute of Urology, University of Padova, Italy
Title: "Renal epithelial injury, cell membrane and crystallization of calcium oxalate."
25
SESSION CHAIRMANSHIPS:
May 11, 2012, Moderator, Mini-Conferences, 12th International Symposium on Urolithiasis, Ouro
Preto, Brazil
May 10, 2012, Moderator, Oral Presentations-Pediatric Stones, 12th International Symposium on
Urolithiasis, Ouro Preto, Brazil
September 9, 2011, Co-Chair, Stones in animals/ Clinical Therapy in humans. Ist Meeting of
European Association of Urology Section of Urolithiasis (EULIS), London, United Kingdom
April 29, 2009, Moderator, Poster Session, Stone Disease: Research/New Technology (1), Annual
Meeting of American Urological Association, Chicago
October 24, 2008, Session Chair, Urology, SIUT 6th International Symposium of Urology,
Nephrology and Transplantation, Karachi, Pakistan
September 4, 2008, Session Chair, Crystal and cells, 11th International Symposium on Urolithiasis,
Nice, France
July 10, 2007, Session Chair, 5th European Urolithiasis Symposium, Lisbon, Portugal
July 19th, 2005, Session Chair, Oxalate Chemistry and Biology, FASEB Summer Research
Conference, Calcium Oxalate in Biological Systems, Tucson, Arizona
June 17th, 2005, Chair, Session on Crystallization, Renal Tubules, 11th European Urolithiasis
Symposium, Coburg, Germany.
April 30th, 2005, Moderator, Session 4, Annual Meeting of the ROCK (Research on Calculus
Kinetics) Society, Chicago, IL.
June 11, 2003, Session Chair, Hyperoxaluria and Related Disorders, 10th European Symposium on
Urolithiasis, Istanbul, Turkey.
August 6, 2002, Session Chair, Crystal-Cell Interactions, 2002 FASEB Summer Research
Conferences, Calcium Oxalate in Biological Systems, August 3-8, Vermont Academy, Saxtons river,
Vermont.
February 16, 2000, Co-Chair, Crystallization Modulators and Macromolecules,
Urolithiasis 2000, 9th International Symposium on Urolithiasis, Cape Town, South Africa.
June 9-12, 1999, Co-Chair: Session on Inhibitors and Promoters, 8th European Symposium on
Urolithiasis, Parma, Italy.
26
March 12-13, 1999, Co-Chair: Session on Diagnostic Approaches, 5th Workshop on Primary
Hyperoxaluria, Kappel, Switzerland.
May 22, 1997, Chairperson, Crystallization Processes, 7th European Symposium on Urolithiasis,
Paris, France.
April 12, 1997, Moderator, Basic Research, Annual Meeting of American Urological Association,
Special Session on Stone Disease sponsored by the R.O.C.K. Society, San Antonio, Texas.
December 27-29, 1993, Co-Chair, Pathogenesis of renal calculi, 7th National Conference of
Urolithiasis Society of India, Madras, India.
April 1-3, 1993, Co-Chair, Session on Calcium metabolism and related problems, 4th European
Symposium on Urolithiasis, Tubingen, Germany
27
HONORS & AWARDS:
2011
MARQUIS Who's Who in America, 66th Edition
2010
Fellow of the American Society of Nphrology
2006
Fellow of the American Society of Nephrology
2001
University of Florida Research Foundation Professor
1997
University of Florida College of Medicine, Award for Excellence in
Research, Faculty Research Prize in Basic Science
1997
Best Poster in Basic Science Research, 97th Annual Meeting of
The American Urological Association, New Orleans, April 16, 1997.
1993
MARQUIS Who's Who in Science and Engineering
1993
Oration Lecture, 7th National Meeting of the Urolithiasis Society of India,
Madras, India
1993
Invited Speaker, State of the Art: Basic Research.
Urolithiasis: State of the Art and Future Needs, Sponsored by
the Division of Kidney, Urologic and Hematologic Diseases, NIDDK, NIH
1992
University of Florida Research Achievement Award
1974-
University Research Fellowship, 1976, University of Adelaide, Australia
1973
Admitted to Academic Honorary Society, Phi Kappa Phi
1972
Admitted to Leadership Honorary Society, Omicron Delta Kappa
1972
Admitted to Scientific Honorary Society, Sigma Xi
1970-73
Fulbright-Hays Scholar, University of Florida, Gainesville
1964
Graduated with Honors from University of Peshawar, Pakistan
1963
Highest Grade in M.Sc. Part I. University of Peshawar, Pakistan
28
CURRENT AND PAST MEMBERSHIP IN PROFESSIONAL SOCIETIES:
American Society for Investigative Pathology
American Society of Nephrology
American Urological Association
The American Society for Bone and Mineral Research
The Society for Basic Urologic Research
New York Academy of Sciences
Society for Biomaterials
Florida Society for Microscopy
Microscopy Society of America
Histochemical Society
29
RESEARCH GRANTS:
Active:
2012-2016
2009-013
Principal Investigator with Dr. Laurie Gower (contact)
NIH, RO1DK092311-01A1
An in vitro model for studying the role of acidic proteins in Randall’s
Plaque and Stone Formation
Principal investigator
NIH, RO1
Crystal Associated Renal Inflammation and Treatment Options
Submitted:
2012
Co-Principal Investigator with Dr. Johannes W.G. Vieweg
NIH, T32 DK 094789
Training Program in Urologic Research
Completed:
2005-2010
2005-2007
Principal Investigator
NIH, RO1
Calcium Phosphate crystals responsible for idiopathic nephrolithiasis
Co-Principal Investigator
NIH, R21
Oxalobacter as a therapy in IBD-associated urolithiasis
2001-2005
Co-Principal Investigator, Bioengineering Research Partnership with
College of Engineering
NIH RO1 DK59765
Role of Bioplymer and Lipids in Kidney Stone Formation
2000-2005
Principal Investigator
NIH RO1DK 53962
Tissue-Crystal Interaction in Calcium Oxalate Neophrolithiasis
1997-2001
Co-Principal Investigator
NIH RO1 DK53556
Regulation of Enteric Hyperoxaluria by Oxalobacter
2000-2003
Co-Principal Investigator,
NIH RO1DK56249
Urolithiasis and Peroxidative Injury
1996-2001
Principal Investigator,
NIH RO1 DK 41434
30
Role of Lipids in Urolithiasis
1999
Principal Investigator,
NIH R13 DK 54761
2nd Finlayson Colloquium on Urolithiasis
1996-97
Director, Program Project on Biophysics of
Urolithiasis,
NIH 5PO1 DK 20586
1997-00
Pathology Core Laboratory
NIH #A1-37281
Malaria-Associated Lactic Acidosis/DCA Trial in
Africa (P.W. Stacpoole, PI)
1992-97
Principal Investigator, Project 2
Program Project on Urolithiasis
NIH 5PO1 DK 20586
1992-97
Principal Investigator, Analytical Core
Program Project
NIH 5PO1 DK 20586
Urolithiasis
1991-95
Principal Investigator
NIH #RO1 DK 41434
Role of Lipids in Urolithiasis
1990
Principal Investigator
University of Florida Division of Sponsored
Research Development Award
1990
Co-Principal Investigator with Dr. Woodard
Kingston Technologies, Catheter Calcification
1987-1992
Co-Principal Investigator with Dr. Hackett
NIH program project grant # 5 PO1 DK20586
Urolithiasis
1978-1987
Co-Investigator with Drs. Hackett and
Finlayson, NIH program project grant
# AM20586
Urolithiasis
31
1974-1973
University Research Fellowship
University of Adelaide,
Adelaide, Australia
1970-1973
Fulbright-Hay's Scholarship
University of Florida
32
LIST OF PUBLICATIONS
Refereed Publications
155
Editorials & Review Articles
23
Edited Books, Proceedings, and Journal Issues
Book Chapters
19
Non Refereed Publications
(Proceedings)
Miscellaneous Publications
(Abstracts, Letters)
Total
6
70
145
419
Refereed Publication:
155. Khan A, Khan SR, Gilani AH, 2012, Studies on the in vitro and in vivo antiurolithic activity of
Holarrhena antidysenterica. Urol Res
154. Khan SR, Rodriguez DE, Gower LB, Monga M, 2012, Association of Randall plaque with
collagen fibers and membrane vesicles. J Urol 187: 1094-1100.
153. Canales BK, Reyes L, Reinhard MK, Khan SR, Goncalves CG, Meguid MM., 2012, Renal
glomerular and tubular injury after gastric bypass in obese rats. Nutrition 28: 76-80.
152. Khan A, Bashir S, Khan SR, Gilani GA, 2011, Antiurolithic activity of Origanum vulgare is
mediated through multiple pathways. BMC Complementary Alter Med 11: 96-111.
151. Khan, SR and Canales BK, 2011, Ultrastructural Investigation of Crystal Deposits in Npt2a
Knockout Mice: Are They Similar to Human Randall's Plaques? J Urol 186: 1107-13
150. Zuo J, Khan A, Glenton PA, Khan SR, 2011. Effect of NADPH oxidase inhibition on the
expression of kidney injury molecule and calcium oxalate crystal deposition in hydroxy-L-prolineinduced hyperoxaluria in the male Sprague-Dawley rats. Nephrology Dialysis Transplantation 26:
1785-1796
149. Khan SR, Glenton PA, 2011. Experimentally induced hyperoxaluria in MCP-1 null mice. Urol
Res. 39: 253-258
33
148. Khan SR, Khan A, Byer K, 2011, Temporal changes in the expression of mRNA of NADPH
oxidase subunits in renal epithelial cells exposed to oxalate or calcium oxalate crystals. Nephrology
Dialysis Transplantation 26: 1778-1785
147. Vanachayangkul P, Chow N, Khan SR, Butterweck V, 2010, Prevention of renal crystal
deposition by an extract of Ammi visnaga L. and its constituents khellin and visnagin in
hyperoxaluric rats. Urol Res 39: 189-195
146. Yan Liu, Lan Mo, David S. Goldfarb, Andrew P. Evan, Fengxia Liang, Khan SR, John C. Lieske
and Xue-Ru Wu1, 2010, Progressive Renal Papillary Calcification and Ureteral Stone Formation in
Mice Deficient for Tamm-Horsfall Protein, American Journal of Physiology (Renal Physiology) 299:
F469-478
145. Khan SR, Glenton, PA, 2010, Experimental induction of calcium oxalate nephrolithiasis in
mice. J Urol., 184: 1189-1196
144. Bashir S, Gilani AH, Siddiqui AA, Pervez S, Khan SR, Sarfaraz NJ, Shah AJ., 2010, Berberis
vulgaris root bark extract prevents hyperoxaluria induced urolithiasis in rats. Phytotherapy Res,
24:1250-1255
143. Vanachayangkul P, Byer K, Khan SR, Butterweck V, 2009, An aqueous extract of Ammi visnaga
fruits and its constituents khellin and visnagin prevent cell damage caused by oxalate in renal
epithelial cells. Phytomedicine 17:653-658
142. Umekawa T, Tsuji H, Uemura H, Khan SR, 2009, Superoxide from NADPH oxidase as second
messenger for the expression of osteopontin and monocyte chemoattractant protein-1 in renal
epithelial cells exposed to calcium oxalate crystals. BJU International 104:115-120.
141. Khaskhali MH, Byer KJ, Khan SR, 2008, The effect of calcium on calcium oxalate monohydrate
crystal-induced renal epithelial injury. Urol Res 37:1-6
140. Amos AF, Dai L, Kumar R, Khan SR, Gower LB, 2008, Mechanism of formation of concentrically
laminated spherules: implication to Randall's plaque and stone formation. Urol Res 37:11-17
139. Yakov I. Rabinovich, Saijit Daosukho, Karen J. Byer, Hassan E. El-Shall , Saeed R. Khan, 2008,
Direct AFM measurements of adhesion forces between calcium oxalate monohydrate and kidney
epithelial cells in the presence of Ca2+ and Mg2+ ions. Journal of Colloid & Interface Science
352:5053-62
138. Escobar C, Byer KJ, Khaskheli H, Khan SR, 2008, Apatite induced renal epithelial injury: insight
into the pathogenesis of kidney stones, J Urol 180:379-387.
34
137. Khan SR, Glenton PA, 2008, Calcium oxalate crystal deposition in kidneys of hypercalciuric
mice with disrupted type IIa sodium-phosphate cotransporter. Am J Physiol Renal Physiol 294:
F1109-1115
136. Yeung LL, Vieweg JW, Khan SR, Robert C. Newman RC and Philipp Dahm P, 2008, A Tribute to
the Life and Accomplishments of Birdwell Finlayson, J Urology 179:842-846
135. Khan SR, Glenton PA, Byer KJ, 2007, Dietary Oxalate and Calcium Oxalate Nephrolithiasis. J
Urology 178:2191-2196
134. Escobar C, Byer KJ, Khan SR. 2007. Naturally produced crystals obtained from kidney stones
are less injurious to renal tubular epithelial cells than synthetic crystals. BJU International 100:891897.
133. Umekawa T, Iguchi M, Uemura H, Khan SR, 2006, Oxalate ions and calcium oxalate crystalinduced up-regulation of osteopontin and monocyte chemoattractant protein-1 in renal
fibroblasts. BJU International 98:656-660.
132. Khan SR, Glenton PA, Byer KJ. 2006, Modeling of hyperoxaluric calcium oxalate
nephrolithiasis: Experimental induction of hyperoxaluria by hydroxy-L-proline. Kidney Intl 70:914923
131. Rabinovich YI, Esayanur M, Daosukho S, Byer K, Khan SR 2006, Adhesion force between
calcium oxalate monohydrate crystal and kidney epithelial cells and possible relevance for kidney
stone formation. J Colloid Interface Sci. 300: 131-140
130. Habibzadegah-Tari P, Byer K, Khan SR. 2006, Reactive oxygen species mediated calcium
oxalate crystal-induced expression of MCP-1 in HK-2 cells. Urol Res 34: 26-36
129. Rabinovich Y, Esaynur M, Daosukho S, Byer K, El-Shall H, Khan S, 2005, Atomic force
microscopy measurement of the elastic properties of the kidney epithelial cells. J Colloid and
Inteface Science 285:125-135
128. Khan SR, 2005, Hyperoxaluria-induced oxidative stress and antioxidants for renal protection.
Urol Res. 33:349-57.
127. Habibzadegah-Tari P, Byer K, Khan SR. 2005, Oxalate induced expression of monocyte
chemoattractant protein-1 (MCP-1) in HK-2 cells involves reactive oxygen species. Urol Res.
33:440-7.
126. Delvecchio FC, Brizuela RM, Khan SR, Byer K, Li Z, Zhong P, Preminger GM., 2005, Citrate and
vitamin E blunt the shock wave-induced free radical surge in an in vitro cell culture model. Urol
Res. 33:448-52
35
125. Umekawa T, Byer K, Uemura H, Khan SR, 2005, Diphenyleneiodium (DPI) reduces oxalate ionand calcium oxalate monohydrate and brushite crystal-induced upregulation of MCP-1 in NRK 52E
cells. Nephrol Dial Transplant. 20:870-878
124. Grewal JS, Tsai JY, Khan SR., 2005, Oxalate-inducible AMBP gene and its regulatory
mechanism in renal tubular epithelial cells. Biochem J. 387:609-616.
123. Byer K and Khan SR, 2005, Citrate provides protection against oxalate and calcium oxalate
crystal induced oxidative damage to renal epithelium. J Urol. 173: 640-646
122. Umekawa T, Hatanaka Y, Kurita T, Khan SR, 2004, Effect of angiotensin II receptor blockage
on osteopontin expression and calcium oxalate crystal deposition in rat kidneys. J Am Soc Nephrol
15: 635-644
121. El-Shall H, Jeon JH, Abdel-Aal EA, Khan S, Gower L, Rabinovich Y, 2004, A study of primary
nucleation of calcium oxalate monohydrate: II. Effect of urinary species. Cryst. Res. Technol. 39,
No. 3, 222 – 229
120. El-Shall H, Jeon JH, Abdel-Aal EA, Khan S, Gower L, Rabinovich Y, 2004, A study of primary
nucleation of calcium oxalate monohydrate: I-Effect of supersaturation. Cryst. Res. Technol. 39,
No. 3, 212 – 219
119. Aihara K, Byer KJ, Khan SR 2003, Calcium phosphate induced renal epithelial injury and stone
formation: involvement of reactive oxygen species. Kidney Intl 64: 1283-1291.
118. Iida S, Ishimatsu M, Chikama S, Inoue M, Matsuoka K, Akasu T, Noda S, Khan SR, 2003,
Protective role of heparin/heparan sulfate on oxalate-induced changes in cell morphology and
intracellular Ca(2+). Urol Res 31: 198-206
117. Umekawa T, Chegini N, Khan SR, 2003, Increased expression of monocyte chemoattractant
protein-1 (MCP-1) by renal epithelial cells in culture on exposure to calcium oxalate, phosphate
and uric acid crystals. Nephrol Dial Transplant. 18:664-9.
116. Thamilselvan S, Khan SR, Menon M, 2003, Oxalate and calcium oxalate mediated free radical
toxicity in renal epithelial cells: effect of antioxidants. Urol Res 31:3-9.
115. Christmas KG, Gower LB, Khan SR, El-Shall H, 2002, Aggregation and dispersion characteristics
of calcium oxalate moonohydrate: effect of urinary species. J Colloid & Interface Science 256: 168174
114. Khan SR, Glenton PA, Backov R Talham DR, 2002, Presence of lipids in urine, crystals and
stones: Implications for the formation of kidney stones. Kidney International 62: 2062-2072.
113. Baggio B, Budakovic A, Pirante G, Gambaro G, Manzato E, Khan SR, 2002, Dietary fatty acid
36
supplementation modulates the urinary excretion of calcium and oxalate in the rat – Insight into
calcium lithogenesis. Nephron 91: 486-491.
112. Khan SR, Johnson JM, Peck AB, Cornelius JG, Glenton PA, 2002, Expression of osteopontin in
rat kidneys: induction during ethylene glycol induced calcium oxalate nephrolithiasis. J Urol 168:
1173-1181.
111. Umekawa T, Chegini N, Khan SR, 2002, Oxalate ions and calcium oxalate crystals stimulate
MCP-1 expression by renal epithelial cells. Kidney International 61: 105-112.
110. Atmani F, Khan SR, 2002, Quantification of proteins extracted from calcium oxalate and
calcium phosphate crystals induced in vitro in the urine of healthy controls and stone-forming
patients. Urol Int 68:54-59.
109. Gokhale JA, Glenton PA., Khan SR, 2001, Characterization of Tamm-Horsfall protein in a rat
nephrolithiasis model. J Urol 166: 1492-1497.
108. Moriyama MT, Glenton PA, Khan SR, 2001, Expression of Inter--inhibitor related proteins in
kidneys and urine of hyperoxaluric rats. J Urol 165: 1687-1692.
107. Fasano JM, Khan SR, 2001, Intratubular crystallization of calcium oxalate in the presence of
membrane vesicles: an in vitro study. Kid Intl 59: 169-178.
106. Maslamani S, Glenton PA, Khan SR, 2000, Changes in urine macromolecular composition
during processing. J Urol 164: 230-236.
105. Thamilselvan S, Byer KJ, Hackett RL, Khan SR, 2000, Free radical scavengers, catalase and
superoxide dismutase provide protection from oxalate-assocaited injury to LLC-PK1 and MDCK
cells. J Urol 164: 224-229.
104. Backov R, Lee CM, Khan SR, Mingotayud C, Fanucci GE, Talham DR, 2000, Calcium oxalate
monohydrate precipitation at phosphatidylglycerol Langmuir monolayers. Langmuir 16: 60136019.
103.Atmani F, Khan SR, 2000, Effects of an extract from Herniaria hirsuta on calcium oxalate
crystallization in vitro. Brit J Urol 85: 621-625.
102. Khan SR, Maslamani SA, Atmani F, Glenton PA, Opalko FJ, Thamilselvan S, Hammett-Stabler C,
2000, Membranes and their constituents as promoters of calcium oxalate crystal formation in
human urine. Calcif Tissue Intl 66, 90-96.
101.Khan SR, Byer KJ, Thamilselvan S, Hackett RL, McCormack WT, Benson NA, Vaughn KL, Erdos
G, 1999, Crystal-cell interaction and apoptosis in oxalate-associated injury of renal epithelial cells. J
Am Soc Nephrol 10: S457-S463.
37
100. Thamilselvan S, Hackett RL, Khan SR, 1999, Cells of proximal and distal tubular origin
respond differently to challenges of oxalate and calcium oxalate crystals. J Am Soc Nephrol 10:
S452-456.
99.
Iida S, Inoue M, Yoshi S, Yanagaki T, Chikama S, Shimada S, Matsuoka K, Noda S, Khan SR,
1999, Molecular detection of heparan sulfate proteoglycan mRNA in rat kidney during calcium
oxalate nephrolithiasis. J Am Soc Nephrol 10: S412-S416.
98.
Atmani F, Khan SR, 1999, Role of urinary bikunin in the inhibition of calcium oxalate
crystallization. J Am Soc Nephrol 10: S385-388.
97.
Backov R, Khan SR, Mingitaud C, Byer K, Lee CM, Talham DR, 1999, Precipitation of calcium
oxalate monohydrate at phospholipid monolayers. J Am Soc Nephrol 10: S359-363.
96.
Sidhu H, Schmidt ME, Cornelius JG, Thamilselvan S, Khan SR, Hesse A, Peck AB, 1999, Direct
correlation between hyperoxaluria/oxalate stone disease and the absence of the gastrointestinal
tract dwelling bacterium Oxalobacter frmigenes: possible prevention by gut recolonization or
enzyme replacement therapy. J Am Soc Nephrol 10: S334-340.
95. Iida S, Peck AB, Byer KJ and Khan, S.R., 1999, Expression of bikunin mRNA in renal epithelial
cells after oxalate exposure. J Urol. 162: 1480-1486.
94. Iida S, Peck AB, Johnson-Tardieu J, Moriyama M, Glenton PA, Byer KJ and Khan, S.R., 1999,
Temporal changes in mRNA expression for bikunin in the kidneys of rats during calcium oxalate
nephrolithiasis. J Am Soc Nephrol .10:986-996.
93. Li DY, Weng Y, Yang BC, Zander DS, Saldeen T, Nichols WW, Khan S, Mehta JL, 1999, Inhibition
of arterial thrombus formation by Apo-A-1-Milano. Arteriosclerosis, Thrombosis and Vascular
Biology (In press).
92. Atmani, F.and Khan, S.R., 1999, Role of inter-alpha-inhibitor and its related proteins in
urolithiasis, I. Purification of an inter-alpha-inhibitor related protein from the bovine kidneys.
Urological Research 27: 57-61.
91. Atmani, F., Glenton, PA and Khan, S.R., 1999, Role of inter-alpha-inhibitor and its related
proteins in experimentally induced calcium oxalate urolithiasis, II. Localization of proteins and
expression of bikunin gene in rat kidneys. Urological Research 27: 63-67.
90. Thamilselvan S, Khan SR, 1998, Oxalate and calcium oxalate crystals are injurious to renal
epithelial cells: results of in vivo and in vitro studies. J Nephrology 11S: 66-69.
89. Whipps, S, Khan, SR, Opalko FJ, Backov R and Talham DR, 1998, Growth of calcium oxalate
monohydrate at phospholipid Langmuir monolayers. J Crystal Growth 192: 243-249.
38
88. Atmani, F., Glenton, PA and Khan, S.R., 1998, Identification of proteins isolated from calcium
oxalate and calcium phosphate crystals induced in the urine of healthy and stone forming subjects.
Urological Research 26: 201-207.
87. Habeger CF, Condon CE, Khan SR, Adair JH, 1997, Evaluation of the calcium oxalate
monohydrate Hamaker constant based on static dielectric constant determination and electronic
polarization. Colloids and Surfaces B: Biointerfaces 10: 13-21.
86. Gokhale, J.A., Glenton, P.A., Khan, S.R., 1997, Biochemical and quantitative analysis of Tamm
Horsfall protein in rats. Urol Res 25(5): 347-354.
85. Opalko FJ, Adair JH, Khan SR, 1997, Heterogeneous nucleation of calcium oxalate trihydrate in
artificial urine by constant composition. J Crystal Growth 181(4):410-417, 1997.
84. Thamilselvan S, Hackett RL, Khan SR, 1997, Lipid peroxidation in ethylene glycol induced
hyperoxaluria and calcium oxalate nephrolithiasis. J Urol, 157: 1059-1063.
83. Khan SR, 1997, Calcium phosphate/calcium oxalate crystal association in urinary stones:
implications for heterogeneous nucleation of calcium oxalate. J Urol 157:376-383.
82. Atmani, F., Mizon J. and Khan, S.R., 1996, Inter-alpha-inhibitor: a protein family involved in the
inhibition of calcium oxalate crystallization. Scann Micros 10: 425-434, 1996
81. Khan SR, Atmani F, Glenton P, Hou Z-C, Talham DR, Khurshid M, 1996, Lipids and membranes
in the organic matrix of urinary calcific crystals and stones. Calcif Tisssue Int 59:357-365.
80. Gokhale, J.A., McKee M.D., Khan, S.R., 1996, Immunocytochemical localization of TammHorsfall protein in the kidneys of normal and nephrolithic rats. Urol Res 24:201-209.
79. Gokhale, J.A., Glenton, P.A., Khan, S.R., 1996, Localization of Tamm-Horsfall protein and
osteopontin in a rat nephrolithiasis model. Nephron 73:456-461.
78. Atmani, F., Mizon J. and Khan, S.R., 1996, Identification of uronic-acid-rich protein as urinary
bikunin, a light cahin of inter-(-inhibitor. Eur J Biochem 236:984-990.
77. Atmani, F., Opalko F.J. and Khan, S.R., 1996, Association of urinary macromolecules with
calcium oxalate crystals induced in vitro in normal human and rat urine. Urol Res 24:45-50.
76. Mehta A, Yang BC, Khan S, Hendricks J, Stephen C, Mehta JL, 1995, Oxidized low density
lipoproteins facilitate leukocyte adhesion to aortic intima without affecting endotheliumdependent relaxation: Role of P-selectin. Atherosclerosis, Thrombosis and Vascular Biology
15:2076-2083.
75. Khan SR and Glenton, P.A., 1996, Increased urinary excretion of lipids by patients with kidney
39
stones. British J Urol 77: 506-511.
74. McKee, M.C., Nanci, A. and Khan, S.R. 1995, Ultrastructural immunodetection of osteopontin
and osteocalcin as major matrix components of renal calculi. J Bone Miner Res 10:1913-1929.
73. Atmani F. and Khan, S.R., 1995, Characterization of uronic-acid-rich inhibitor of calcium oxalate
crystallization isolated from rat urine. Urological Research 23:95-101.
72. Woodard, J. C., Riser W.H., Morrone A.A. and Khan S.R., 1995, Articular chondrocalcinosis of
the humeral head in greyhounds. Am. J. Vet. Res., 56: 473-480.
71. Hackett, R.L., Shevock, P.N. and Khan, S.R. 1995, Alterations in MDCK and LLC-PK1 cells
exposed to oxalate and calcium oxalate monohydrate crystals. Scann Microsc 9: 587-596.
70. Khan, S.R. and P.A. Glenton, 1995, Deposition of calcium phosphate and calcium oxalate
crystals in the kidneys. Journal of Urology, 153: 811-817.
69. Kok, D.J. and S. R. Khan, 1994, Calcium oxalate nephrolithiasis, a free or fixed particle disease.
Kidney International, 46: 847-854.
68. Hackett, R.L., Shevock, P.N. and S.R. Khan, 1994, Madin-Darby Canine Kidney Cells are injured
by exposure to oxalate and calcium oxalate crystals. Urological Research, 22: 197-204.
67. Yang, B.C., S. Khan and J.L. Mehta 1994, Blockade of platelet-mediated relaxation in rat aortic
rings exposed to xanthine-xanthine oxidase. American Journal of Physiology 35:H2212-2218.
66. Nichols, W.W., Nicolini, F.A., S. Khan, Saldeen, T.G.P. and J.L. Mehta 1993, Failure of
prostacyclin analog iloprost to sustin coronary blood flow after recombinant tissue type
plasminogen-induced thrombolysis in dogs. American Heart Journal 126:285-292.
65. Shevock, P.N., S.R. Khan and R.L. Hackett 1993, Urinary chemistry of the normal SpragueDawley rat. Urological Research 21:309-312.
64. Khan, S.R., P.O. Whalen and P.A. Glenton 1993, Heterogeneous nucleation of calcium oxalate
crystals in the presence of membrane vesicles. J. Crystal Growth 134:211-218.
63. Khan, S.R. and R.L. Hackett 1993, Role of organic matrix in urinary stone formation: an
ultrastructural study of crystal matrix interface of calcium oxalate monohydrate stones. Journal of
Urology 150:239-245.
62. Khan, S.R., P.N. Shevock, and R.L. Hackett 1993, Magnesium oxide administration and
prevention of calcium oxalate nephrolithiasis. Journal of Urology 149:412-416.
61. Nicolini, F.A., W.W. Nichols, T.G.P. Saldeen, S. Khan, J.L. Mehta 1992; Adjunctive therapy with
low molecular weight heparin with rt-PA causes sustained reflow in canine coronary thrombosis.
40
American Heart Journal. 124:280-288.
60. Norman, S., S.R. Khan, P. Leelachaikul, D.R. Saloman 1992, Origin of cells in the coronary
intima during acute vascular rejection of the transplanted human heart. Journal of Heart and Lung
Transplantation, 11: 492-499.
59. Khan, S.R., P.N. Shevock, and R.L. Hackett 1992, Acute hyperoxaluria, renal injury and calcium
oxalate urolithiasis. Journal of Urology, 147: 226-230.
58. Gokhale, J.A. and S.R. Khan 1992, Structure of rat kidney following microwave accelerated
fixation. Scanning Microscopy, 6:511-519.
57. Khan, S.R. and R.L. Hackett 1991, Retention of calcium oxalate crystals in renal tubules.
Scanning Microscopy, 5:707-712.
56. Kumar, S., D. Sigmon, T. Miller, B. Carpenter, S. Khan, R. Malhotra, C. Sheid and M. Menon
1991, A new model of nephrolithiasis involving tubular dysfunction/injury. Journal of Urology, 146,
1384-1389.
55. Normann, S.J., D.R. Saloman, P. Leelachaikul, S.R. Khan, E. Staples, J.A. Alexander, W.R.
Mayfield, L.A. Sadler, and S. Selman 1991, Acute vascular rejection of the coronary arteries in
human heart transplantation: pathology and correlations with immunosuppression and
cytomegalovirus (CMV) infection, Journal of Heart Transplantation, 10: 674-687.
54. Su, Chung-Jen, P.N. Shevock, S.R. Khan, and R.L. Hackett 1991, Effect of magnesium oxide
administration on calcium oxalate urolithiasis. Journal of Urology, 145: 1092-1095.
53. Hackett, R.L., P.N. Shevock, P.N. and S.R. Khan 1990. Cell injury associated calcium oxalate
crystalluria. Journal of Urology, 144, 1535-1538.
52. Khan, S.R. and E.J. Wilkinson 1990. Bladder stone in a human female: the case of an
abnormally located intrauterine contraceptive device. Scanning Microscopy, 4: 395-398.
51. Klimberg, V.S., Souba W.W., Dolson, D.J., Salloum, R.M., Hautamaki, R.D., Plumley, D.A.,
Mendenhall, W.M., Bova, F.J., Khan, S.R., Hackett, R.L., Bland, K.I. and E.M. Copeland 1990:
Prophylactic glutamine protects the intestinal mucosa from radiation injury. Cancer, 66: 62-68.
50. Khan, S.R., P.N. Shevock and R.L. Hackett 1990. Membrane associated crystallization of calcium
oxalate in vitro. Calcified Tissue International, 46: 116-120.
49. Khan, S.R., P.N. Shevock, and R.L. Hackett 1989. Urinary Enzymes and Calcium Oxalate
Urolithiasis. J. Urol. 142, 846-849.
48. Khan, S.R., P.N. Shevock and R.L. Hackett 1988. Presence of lipids in urinary stones: results of
41
preliminary studies. Calcified Tissue International 42, 91-96.
47. Benny G.L. and S.R. Khan 1988. Calcium oxalate crystals on the surface of some mucoralean
fungi. Scanning Microscopy 2, 1199-1206.
46. Khan, S.R., P.N. Shevock and R.L. Hackett 1988. In vitro precipitation of calcium oxalate in the
presence of whole matrix or lipid components of the urinary stones. J. Urol 139, 418-422.
45. Hackett, R.L. and S. R. Khan 1987. Presence of calcium oxalate crystals in the mammalian
thyroid gland. Scanning Microscopy 2, 241-246.
44. Khan, S.R. and R.L. Hackett 1987. Crystal-matrix relationship in experimentally induced urinary
calcium oxalate monohydrate crystals, an ultrastructural study. Calcified Tissue International, 41,
157-163.
43. Khan, S.R. and R.L. Hackett 1987. Role of scanning electron microscopy and x-ray microanalysis
in the identification of urinary crystals. Scanning Microscopy, 1, 1405-1411.
42. Khan, S.R. and R.L. Hackett 1987. Urolithogenesis of mixed foreign body stones. J. Urol. 138,
1321-1328.
41. Baird R.E., and S.R. Khan, 1987. Spore ornamentation of north american Phellodon species.
Mycologia 79, 334-337.
40. Khan, S.R., B. Finlayson, and R.L. Hackett, 1986. Morphology of urinary stone particles resulting
from ESWL treatment. J. Urol., 136, 1367-1372.
39. Khan, S.R. and R.L. Hackett, 1986. Scanning electron microscopic histochemistry of colloidal
iron stained calcium oxalate crystal associated material in human urinary stones and
experimentally induced intrarenal deposits in rats. Scan. Electr. Microsc/II/ 761-765.
38. Baird, R.E., and S.R. Khan, 1986. The stipitate Hydnums (Thelephoraceae) of Florida. Brittonia
38:171-184.
37. Khan, S.R., and R.L. Hackett, 1986. Identification of urinary stone and sediment crystals by
scanning electron microscopy and x-ray microanalysis. J. Urol. 135, 818-825.
36. Khan, S.R. and R.L. Hackett, 1985. Calcium oxalate urolithiasis in the rat: Is it a model for
human urinary stone disease? A review of recent literature. Scan. Electr. Microsc./II/ 759-774.
35. Khan, S.R. and E.J. Wilkinson, 1985. Scanning electron microscopy as an analytical tool for the
study of calcified intrauterine contraceptive devices. Scan. Electr. Microsc./III/ 1247-1251.
34. Khan, S.R. and E.J. Wilkinson, 1985. Scanning electron microscopy, x-ray diffraction, and
42
electron microprobe analysis of calcific deposits on intrauterine contraceptive devices. Human
Pathology, 16, 732-738.
33. Khan, S.R., and R.L. Hackett, 1985. Developmental morphology of calcium oxalate foreign body
stones in rats. Calcified Tissue International, 37, 165-173.
32. Khan, S.R., B. Finlayson, W.C. Thomas, Jr., R.L. Hackett, 1984. Relationship between
experimentally induced crystalluria and relative supersaturation of various stone salts in
rats. Urol. Res., 12, 271-273.
31. Khan, S.R., and R.L. Hackett, 1984. Microstructure of decalcified human calcium oxalate
urinary stones. Scan. Electr. Micros./II, 935-941.
30. Khan, S.R., Charles A. Cockrell, B. Finlayson and R.L. Hakcett, 1984. Crystal retention by injured
urothelium of the rat urinary bladder. J. Urol. 132, 153-157.
29. Khan, S.R., B. Finlayson and R.L. Hackett, 1984. Renal papillary changes in a patient with
calcium oxalate lithiasis. Urology 23, 194-199.
28. Khan, S.R., B. Finlayson and R.L. Hackett, 1983. Agar embedded urinary stones: a technique
useful for studying microscopic architecture. J. Urol. 130, 992-995.
27. Khan, S.R., B. Finlayson and R.L. Hackett, 1983. Experimental induction of crystalluria in rats
using mini-osmotic pumps. Urol. Res. 11, 199-205.
26. Khan, S.R., B. Finlayson and R.L. Hackett, 1983. Stone matrix as proteins adsorbed on crystal
surfaces: a microscopic study. Scan. Electr. Micros. /83/ I, 379-385.
25. Khan, S.R., B. Finlayson and R.L. Hackett, 1982. Structural changes in the rat renal papilla
during oxalate nephrolithiasis. Am. J. Path. 107, 59-69.
24.Khan, S.R., B. Finlayson and R.L. Hackett, 1981. Light and scanning electron microscopic studies
of oxamide urolithiasis in rats. Scan. Electr. Micros. /81/ III, 155-162.
23. Khan, S.R., and R.L. Hackett, 1980. The use of SEM in the study of oxalate
induced experimental nephrolithiasis. Scan. Electr. Micros. /80/ III, 379-386.
22. Khan, S.R., B. Finlayson and R.L. Hackett, 1979. Scanning electron microscopy of calcium
oxalate crystal formation in experimental nephrolithiasis. Lab. Invest. 41, 504-510.
21.Khan, S.R., B. Finlayson and R.L. Hackett, 1979. Histological study of the early events in oxalate
induced intranephronic calculosis. Invest. Urol. 17, 199-202.
20. Khan, S.R. and J.W. Kimbrough, 1982. A reevaluation of the Basidiomycetes based upon septal
43
and basidial structures. Mycotaxon. 15, 103-120.
19. Khan, S.R., J.W., Kimbrough and P. Webb, 1982. Fine structure of the dikaryotic mycelium of
the Cronortium quercum fuciforme on Quercus rubra L. Mycologia 74, 809-819.
18. Khan, S.R., J.W. Kimbrough and K.J. KwonChung, 1981. Ultrastructure of Filobasidiella
arachnophila. Can. J. Bot. 59, 893-897.
17. Khan, S.R., J.W. Kimbrough and C.W. Mims, 1981. Septal ultrastructure and taxonomy of
Exobasidium. Can. J. Bot. 59, 2450-2457.
16. Khan, S.R. and J.W. Kimbrough, 1980. Ultrastructure and taxonomy of Eocronortium.
Can. J. Bot. 58, 642-647.
15. Khan, S.R. and J.W. Kimbrough, 1979. Ultrastructure of septal pore apparatus in the lamellae
of Nematolomma puiggarii. Can. J. Bot. 57, 2064-2070.
14. Khan, S.R. and J.W. Kimbrough, 1979. Septal ultrastructure in Tremellaceae. Can. J. Bot. 57, 5580.
13.Khan, S.R. 1978. The golgi cisternae of Cunninghamella echinulata. Can. J. Bot. 56, 432438.
12. Khan, S.R. 1977. Light and electron microscopic observations of sporangium formation in
Albugo candida (Peronosporales: Oomycetes). Can. J. Bot. 55, 730-739.
11. Khan, S.R. 1976. Ultrastructure of the septal pore apparatus of Tremella. J. Gen. Microbiol. 97,
339-342.
10. Khan, S.R. 1976. Ultrastructural changes in maturing sporangia of Albugo candid. Ann. Bot. 40,
1285-1292.
9. Khan, S.R. and P.H.B. Talbot, 1976. Ultrastructure of septa in hyphae and basidia of
Tulasnella. Mycologia 68, 1027-1036.
8. Khan, S.R. 1976. Paramural bodies of Albugo candida. Arch. Microbiol. 109, 271-276.
7.Khan, S.R. 1976. Electron microscopic observations of dividing somatic nuclei in Albugo.
Can. J. Bot. 54, 168-172.
6.Khan, S.R. 1975. Wall structure and germination of spores in Cunninghamella echinulata.
J. Gen. Microbiol. 90, 115-124.
5.Khan, S.R. and P.H.B. Talbot, 1975. Monosporous sporangiola in Mycotypha and
44
Cunninghamella. Trans. Br. Mycol. Soc. 65, 29-30.
4. Khan, S.R. and H.C. Aldrich, 1975. The haustoria of Termitaria snyderi Thax. J. Invert. Pathol. 25,
247-260.
3.Khan, S. R. and J.W. Kimbrough, 1974. Morphology and development of Termitaria
snyderi. Thax. Mycologia 66, 446-462.
2.Khan, S.R. and J.W. Kimbrough, 1974. Taxonomic position of Termitaria and Mattirolella
(Entomogenous Deuteromycets). Am. J. Bot. 61, 395-399.
1.Khan, S.R. and H.C. Aldrich, 1973. Conidiogenesis in Termitaria snyderi Thax. (Fungi
Imperfecti). Can. J. Bot. 51, 2307-2314.
45
BOOKS, PROCEEDINGS & JOURNAL SPECIAL ISSUES:
6. Rodgers AL, Hibbert BE, Hess B, Khan SR, Preminger GM, Editors, Urolithiasis 2000 Vols 1
and 2, Proceedings of the 9th International Symposium on Urolithiasis, University of Cape Town,
Rondebosch, Cape Town, South Africa, 2000.
5. Joseph W. Segura and Khan SR, Guest-Editors, J Endourology, Vol13 (9).
4. Khan, S.R., Guest Editor, Supplement 14, J Am Soc Nephrol 14:S323-S366, 1999.
3. Khan, S.R., Editor, Calcium Oxalate in Biological Systems, CRC Press, Boca Raton, 373 pages,
1995.
2. Khan, S.R., Guest Editor, Special Issue, Stones and Crystals, Scanning Microscopy Vol. 10 (2),
Scanning Microscopy International, Chicago, pages 303-612, 1996.
1. Khan, S.R., Guest Editor, Proceedings of the Finlayson Colloquium, American Journal of Kidney
Diseases 17 (4), pages 363-458, 1991.
BOOK CHAPTERS:
19. Khan SR, 2011, Renal Cellular Dysfunction/Damage and the Formation of Kidney Stones, In:
Urinary Tract Stone Disease (NP Rao, GM Preminger, JP Kavanagh, eds.), Springer-Verlag London,
61-86
18. Khan SR, 2008, Macromolecules in Urinary Stone Formation and Urinary Inhibitors, In: Uriner
Sistem Tas Hastaligi (AH Muslumanoglu, T Esen, A Tefekli, eds.), Nobel Tip Kitabevleri, Istanbul,
Turkey, 27-56 (In Turkish)
17. Khan SR, Kok DJ, 2007, Modulators of crystallization of stone salts, In: Urinary Stone disease,
The practical guide to medical and surgical management (ML Soller and MV Meng, eds.), Humana
Press Inc, NJ, USA, 175-219.
16. Amos FA, Olszta MJ, Khan SR, Gower LB, 2006, Relevance of a polymer-induced liquidprecursor (PILP) mineralization process to normal and pathological biomineralization, In:
Biomineralization Medical Aspects of Solubility (E and L-C Konigsberger, eds.) , John Wiley & Sons,
Ltd, England, 125-217
15. Tiselius H-G, Borghi L, Brandle E, Buck C, Coe F, Hautmann R, Khan SR, Ryall RL, Schor N,
Member, Biochemistry Committee, In: Stone Disease (J Segura , P Conort, S Khoury, C Pak, GM
Preminger, D Tolley, eds.), First International Consultation on Stone Disease, held Paris 2001,
Health Publications-2003, Paris, France, 31-122
14. Khan, S.R., 1997. Importance of calcium phosphates in the development of calcium
46
urolithiasis. In: Calcium Phosphates in Biological and Industrial Systems (Amjad, Z., ed.) Kluwer
Academic Publishers, Boston, 252-275.
13. Khan, S.R., 1997. Calcium oxalate urolithiasis, rat. In: Urinary System, Monographs on
Pathology of Laboratory Animals, Sponsored by International Life Sciences Institute (T.C. Jones, U.
Mohr and R.T. Hunt, eds.), Springer-Verlag, New York, 4311-438.
12. Atmani, F., Gokhale, J.A., Khan, S.R., 1997. Urinary glycoprotein modulators of calcific
nephrolithiasis. In: Urinary System, Monographs on Pathology of Laboratory Animals, Sponsored
by International Life Sciences Institute (T.C. Jones, U. Mohr and R.T. Hunt, eds.), Springer-Verlag,
New York,438-450.
11. Khan, S.R., 1997. Phosphate urolithiasis, rat. In: Urinary System, Monographs on Pathology of
Laboratory Animals, Sponsored by International Life Sciences Institute (T.C. Jones, U. Mohr and
R.T. Hunt, eds.), Springer-Verlag, New York,451-456.
10. Khan, S.R., 1995. Association between calcium phosphate and calcium oxalate crystals in the
development of urinary stones. In: Mineral Scale Formation and Inhibition (Amjad, Z., ed.), Plenum
Press, New York, 261-270.
9. Adair, James H., Linhart R.V., Habeger F. and Khan, S.R., 1995. Mechanisms of calcium oxalate
aggregation in the biophysical environment. In: Calcium Oxalate in Biological Systems (Khan, S.R.,
ed.), CRC Press, Boca Raton, 37-52.
8. Khan, S.R., 1995. Animal model of calcium oxalate nephrolithiasis. In: Calcium Oxalate in
Biological Systems (Khan, S.R., ed.), CRC Press, Boca Raton, 343-359.
7. Khan, S.R., 1995. Lipid matrix of urinary calcium oxalate crystals and stones. In: Calcium Oxalate
in Biological Systems (Khan, S.R., ed.), CRC Press, Boca Raton, 291-304.
6. Khan, S.R., Adair, J.H., Morrone, A.A. and G.P. Latorre, 1994, Calcium Phosphate Deposition in
Rat Kidneys. In: Hydroxyapatite and Related Materials, (P.W. Brown and B. Constantz, eds.), CRC
Press, Boca Raton, 325-329.
5. Khan, S.R., Hackett, R.L., 1994. Pathological crystallization of calcium oxalate and calcium
phosphate. In: Hydroxyapatite and Related Materials, (P.W. Brown and B. Constantz, eds.), CRC
Press, Boca Raton, 83-92.
4. Khan, S.R., 1992. Structure and development of calcific urinary stones. In: Calcification in
biological systems, (E. Bonnuci, ed.), CRC Press, Boca Raton, 345-363.
3. Finlayson, B., Khan, S.R. and R.L. Hackett, 1990. Theoretical chemical models of urinary stones.
In: Renal Tract Stones, Metabolic Basis and Clinical Practice, (J.E.A. Wickham and A.C. Buck, eds.),
Churchill and Livingstone., New York, 133-147.
47
2. Khan, S.R., and J. Carroll Woodard, 1986. Calcium oxalate urolithiasis, rat. In: Urinary System,
Monographs on Pathology of Laboratory Animals, Sponsored by International Life Sciences
Institute (T.C. Jones, U. Mohr and R.T. Hunt, eds.), Springer-Verlag, New York, 355-361.
1.Woodard, J. Carroll, and S.R. Khan, 1986. Phosphate urolithiasis, rat. In: Urinary System,
Monographs on Pathology of Laboratory Animals, Sponsored by International Life Sciences
Institute (T.C. Jones, U. Mohr and R.T. Hunt, eds.), Springer-Verlag, New York, 364-369.
48
REVIEW ARTICLES:
23. Khan SR, 2012, Is oxidative stress, a link between nephrolithiasis and obesity, hypertension,
diabetes, chronic kidney disease, metabolic syndrome? Urol Res. 40: 95-112.
22. Khan SR, 2011, Crystal/Cell interaction and nephrolithiasis. Arch Ital di Urolog, Androl 83: 1-5.
21. Khan SR, Canales B K., 2009, Genetic basis of renal cellular dysfunction and the formation of
kidney stones. Urol Res 37: 169-180
20. Butterweck V, Khan SR, 2009, Herbal Medicines in the Management of Urolithiasis: Alternative
or Complementary? Planta Medica
19. Talham DR, Backov R, Benitez IO, Sharbaugh DM, Whipps S, Khan SR., 2006, Role of lipids in
urinary stones: studies of calcium oxalate precipitation at phospholipid langmuir monolayers.
Langmuir 22: 2450-06.
18. Khan SR, 2006, Renal tubular damage/dysfunction: key to the formation of kidney stones. Urol
Res 34: 86-91.
17. Khan SR, 2005, Hyperoxaluria-induced oxidative stress and antioxidants for renal protection.
Urol Res. 33:349-57.
16. Khan SR, 2004, Role of renal epithelial cells in the initiation of calcium oxalate stones. Nephron
Exp Nephrol 98:55-60
15. Khan SR, 2004, Crystal-induced inflammation of the kidneys: results from human studies,
animal models, and tissue culture studies. Clinical and Experimental Nephrology 8:75-88.
14. Khan SR and Kok DJ, 2004, Modulators of Urinary Stone Formation, Frontiers in Bioscience 9,
1450-1482
13. Khan SR, 2002, Stone research on the bench: where we are and where we are going. Text of
the First Finlayson Memorial Lecture given at the annual ROCK Society meeting, Orlando, Florida; J
Endourology 16 (6) 413-416.
12. Hess B, Ryall RL, Kavanagh JP, Khan SR, Kok DJ, Rogers AL, Tiselius HG, 2001, Methods for
measuring crystallization in urolithiasis research: why, how and when? Eur Urol 40: 220-230.
11. Khan SR, Thamilselvan S, 2000, Nephrolithiasis: a consequence of renal epithelial cell exposure
to oxalate and calcium oxalate crystals. Mol Urol 4 (4): 305-311.
10. Khan SR, 1997, Animal models of kidney stone formation: an analysis. World J Urol. 15: 236243.
49
9. Khan SR, 1997, Intercations between stone forming calcific crystals and macromolecules.
Urologia Internationalis, 59: 59-71.
8. Khan SR, 1997, Tubular cell surface events during nephrolithiasis. Curr Opin in Urol, 7: 240-247.
7. Khan SR, 1996, Where do renal stone form and how? It J Min Electr Metabolism, 10:75-82.
6. Khan, S.R. 1995, Heterogeneous nucleation of calcium oxalate crystals in mammalian urine.
Scann Microsc 9:597-616.
5. Khan, S.R.,1995, Mechanisms involved in calcium oxalate nephrolithiasis based on studies in an
animal model. Italian J. Min Electr. Met. 9:3-9.
4. Khan, S.R., 1995, Calcium oxalate crystal interaction with renal tubular epithelium, mechanism
of crystal adhesion and its impact on stone development. Urological Research 23:71-79.
3. Khan, S.R. 1995, Experimental calcium oxalate nephrolithiasis and the formation of human
urinary stones. Scann Microsc 9:89-101
2. Khan, S.R., 1991, Pathogenesis of oxalate urolithiasis: Lessons from experimental studies with
rats. American Journal of Kidney Diseases 17: 398-401.
1. Finlayson, B., S.R. Khan and R.L. Hackett, 1984. Mechanisms of urinary stone formation: an
overview. Scan. Electr. Micros. /84/III, 1419-1425.
50
NON-REFEREED PUBLICATIONS (Proceedings):
70. Khan SR, 2011, Crystal-Cell Interaction and nephrolithiasis. Arch Ital Urol Androl 83: 1-5.
69. Gower LB, Amos FF, Khan SR., 2010, Mineralogical signatures of stone formation mechanisms.
Urol Res., 38:281-92
68. Khan SR, 2010, Nephrocalcinosis in animal models with and without stones. Urol Res. 38: 429438.
67. Khan SR, 2004, Animal models of calcium oxalate nephrolithiasis. In: Kidney Stones: Inside and
Out (Eds. MDI Gohel & DWT Au), Proceedings of the 10th International Symposium on Urolithiasis,
Hong Kong, May 25-28, 420-425.
66. Umekawa T, Byer KJ, Khan SR, 2004, NADPH oxidase as source of reactive oxygen species in
oxalate and calcium oxalate induced injury of renal epithelial cells. In: Kidney Stones: Inside and
Out (Eds. MDI Gohel & DWT Au), Proceedings of the 10th International Symposium on Urolithiasis,
Hong Kong, May 25-28, published by The Hong Kong Polytechnic University, pp118-119.
65. Khan SR, Byer KJ, 2004, Possible protective role for citrate during crystal induced injury. In:
Kidney Stones: Inside and Out (Eds. MDI Gohel & DWT Au), Proceedings of the 10th International
Symposium on Urolithiasis, Hong Kong, May 25-28, 64-65.
64. Rabinovich Y, Esayanur M, Daosukho S, Byer K, El-Shall H, Gower L, Khan S, 2003, Direct
measurement of the interaction force between calcium oxalate monohydrate and biological Cells.
In: Urolithiasis, Proceedings of the 2nd Eurolithiasis Society Meeting, Istanbul June 11-14, 1-2
63. Diaz-Diurych CC, Raval AJ, Byer KJ, Khan SR, 2003, Involvement of calcium phosphate in
idiopathic calcium oxalate nephrolithiasis. In: Urolithiasis, Proceedings of the 2nd Eurolithiasis
Society Meeting, Istanbul June 11-14, 7-8.
62. Grewal JS, Tsai JY, Glenton PA, Byer KJ, Khan SR, 2003, Exposure to oxalate and calcium oxalate
crystals induces the expression and production of an immunosuppressive lipocalcin, alpha-1microglobulin in LLC-PK1 cells via intermediating reactive oxygen species. In: Urolithiasis,
Proceedings of the 2nd Eurolithiasis Society Meeting, Istanbul June 11-14, 9
61. Umekawa T, Chegini N, Khan SR, 2003, Crystal induced expression of MCP-1 in renal epithelial
cells in culture. In: Urolithiasis, Proceedings of the 2nd Eurolithiasis Society Meeting, Istanbul June
11-14, 13
60. El-Shall H, Jeon JH, Daosukho S, Rabinovich Y, Gower L, Khan S, 2003, Effect of citrate on
nucleation and crystal growth of calcium oxalate monohydrate, In: Urolithiasis, Proceedings of the
2nd Eurolithiasis Society Meeting, Istanbul June 11-14, 69-70
51
59. Umekawa T, Chegini N, Khan SR 2001, Calcium oxalate nephrolithiasis as an inflammatory
disease, production of MCP-1 by renal epithelial cells exposed to xoalate and calcium oxalate
crystals. In: Eurolithiasis, (DJ Kok, HC Romjin, PCMS Verhagen, CF Verkoelen, editors), Proceedings
of the 9th European Symposium on Urolithiasis held September 13-15, 2001, Rotterdam, The
Nerherlands, 23-26.
58. Thamilselvan S, Khan SR, Menon M, 2000, Antioxidant protecting against oxalate injury in renal
epithelial cells. In: Abstract booklet of the Workshop on Oxalosis and Calcium Oxalate Stone
Disease, held Nov 16-17, Columbia, Maryland, Presented by The NIDDK, NIH; page 49.
57. Khan SR, 2000, Animal model of hyperoxaluria, experimental induction. In: Abstract booklet of
the Workshop on Oxalosis and Calcium Oxalate Stone Disease, held Nov 16-17, Columbia,
Maryland, Presented by The NIDDK, NIH; pages 6-7.
56. Khan SR, Fasano JM, Backov R, Talham DR, 2000, Involvement of cellular membranes and their
lipids in nucleation of stone forming crystals. In: Mineralization in Natural and Synthetic
Biomaterials, edited by P. Li. P. Calvert, T. Kokubo, R. Levy, and C Scheid, Proceedings of Materials
Research Society Symposium, held November 29-Dec 1, 1999, Boston, MA, Vol 599: 269-279.
55. Glenton PA, Khan SR, 2000, Renal brush border membrane lipids of normal and hyperoxaluric
rats. In: Urolithiasis 2000, edited by Rodgers RL, Hibbert BE, Hess B, Khan SR, Preminger GM,
Proceedings of the 9th International Symposium on Urolithiasis, held February 13-17, 2000, Cape
Town, South Africa, University of cape Town, Rondebosch, Cape Town, South Africa, 287-288.
54. Glenton PA, Khan SR, 2000, Lipid comparison of five types of kidney stones. In: Urolithiasis
2000, edited by Rodgers RL, Hibbert BE, Hess B, Khan SR, Premionger GM, Proceedings of the 9th
International Symposium on Urolithiasis, held February 13-17, 2000, Cape Town, South Africa,
University of cape Town, Rondebosch, cape Town, South Africa, 285-286.
53. Thamilselvan S, Khan SR, 2000, Free radical scavengers, catalase and superoxide dismutase,
provide protection from oxalate-associated injury to LLC-PK and MDCK cells. In: Urolithiasis 2000,
edited by Rodgers RL, Hibbert BE, Hess B, Khan SR, Premionger GM, Proceedings of the 9th
International Symposium on Urolithiasis, held February 13-17, 2000, Cape Town, South Africa,
University of cape Town, Rondebosch, cape Town, South Africa, 229-231.
52. Khan SR, 2000, Crystal-cell interaction: the backbone of stone formation. In: Urolithiasis 2000,
edited by Rodgers RL, Hibbert BE, Hess B, Khan SR, Premionger GM, Proceedings of the 9th
International Symposium on Urolithiasis, held February 13-17, 2000, Cape Town, South Africa,
University of cape Town, Rondebosch, cape Town, South Africa, 211-217.
51. Christmas KG, Gower LA, Adair JH, Khan SR, El-Shall H, 2000, Aggregation/dispersion
chracteristics of calcium oxalate monohydrate crystals in the presence of protein and urinary ions.
In: Urolithiasis 2000, edited by Rodgers RL, Hibbert BE, Hess B, Khan SR, Premionger GM,
Proceedings of the 9th International Symposium on Urolithiasis, held February 13-17, 2000, Cape
52
Town, South Africa, University of cape Town, Rondebosch, cape Town, South Africa, 178-180.
50. Johnson-Tardieu J, Glenton PA, Moriyama M, Peck AB, Khan SR, 2000, Expression of inter-(inhibitor related proteins in kidneys and urine of hyperoxaluric rats. In: Urolithiasis 2000, edited by
Rodgers RL, Hibbert BE, Hess B, Khan SR, Premionger GM, Proceedings of the 9th International
Symposium on Urolithiasis, held February 13-17, 2000, Cape Town, South Africa, University of cape
Town, Rondebosch, cape Town, South Africa, 148-149.
49. Khan SR, McKee MD, 2000, Ultrastructural localization of matrix molecules in human kidney
stones. In: Urolithiasis 2000, edited by Rodgers RL, Hibbert BE, Hess B, Khan SR, Premionger GM,
Proceedings of the 9th International Symposium on Urolithiasis, held February 13-17, 2000, Cape
Town, South Africa, University of cape Town, Rondebosch, cape Town, South Africa, 144-145.
48. Johnson-Tardieu J, Glenton PA, Moriyama M, Peck AB, Khan SR, 2000, Osteopontin expression
in kidneys and urine of rats with hyperoxaluria and nephrolithiasis. In: Urolithiasis 2000, edited by
Rodgers RL, Hibbert BE, Hess B, Khan SR, Premionger GM, Proceedings of the 9th International
Symposium on Urolithiasis, held February 13-17, 2000, Cape Town, South Africa, University of cape
Town, Rondebosch, cape Town, South Africa, 142-143.
47. Fasano JM, Khan SR, 2000, Intratubular crystallization in the presence of renal epithelial
membrane vesicles. In: Urolithiasis 2000, edited by Rodgers RL, Hibbert BE, Hess B, Khan SR,
Premionger GM, Proceedings of the 9th International Symposium on Urolithiasis, held February
13-17, 2000, Cape Town, South Africa, University of cape Town, Rondebosch, cape Town, South
Africa, 52-54.
46.Atmani F, Khan SR, 1999, Urinary bikunin as a natural inhibitor of calcium oxalate
crystallization. In: Kidney Stones, edited by Borghi L, Meschi T, Briganti A, Schianchi T, Novarini A,
Proceedings of the 8th European Sympsoium on Urolithiasis, held in Parma, Italy; Editoriale Bios,
page 257.
45. Khan SR, 1999, Oxalate and calcium oxalate crystals provoke renal epithelial cells: results of
studies in rat models. In: Abstract booklet of the Workshop on New Horizons in the Pathogenesis,
Treatment & Cure of Hyperoxaluria, Oxalosis & the Oxalate Stone Diseases, held Bethesda,
Maryland, Presented by The NIDDK, NIH; page20.
44. Khan SR, 1999, Renal epithelial cells are provoked by exposure to both oxalate and calcium
oxalate crystals: results of studies in a rat model of nephrolithiasis. Nephrol Dial Transplant 14:
2786.
43. Khan SR, Glenton PA, Byer KJ, 1999, Hyperoxaluric calcium oxalate stone forming rats. In:
Abstract booklet of 2nd Finlayson Colloquium on urolithiasis, held Gainesville, Florida, sponsored
by ROCK Society; page 45.
42. Atmani F, Khan SR, 1999, Role of urinary bikunin in the inhibition of calcium oxalate
53
crystallization. In: Abstract booklet of 2nd Finlayson Colloquium on urolithiasis, held Gainesville,
Florida, sponsored by ROCK Society; page 38.
41. Byer, KJ, McCormack WT, Benson NA, Khan SR, 1999. Apoptosis in oxalate-associated injury of
renal epithelial cells. In: Abstract booklet of 2nd Finlayson Colloquium on urolithiasis, held
Gainesville, Florida, sponsored by ROCK Society; page 34.
40. Thamilselvan S, Khan SR, 1999, Cells of proximal and distal tubular origin respond differently to
challenges of oxalate and calcium oxalate crystals. In: Abstract booklet of 2nd Finlayson
Colloquium on urolithiasis, held Gainesville, Florida, sponsored by ROCK Society; page 32.
39. Fasano JM, Khan SR, 1999, Intratubular crystallization in the presence of renal tubular brush
border membrane vesicles. In: Abstract booklet of 2nd Finlayson Colloquium on urolithiasis, held
Gainesville, Florida, sponsored by ROCK Society; page 22.
38. Backov R, Khan S.R., Mingotaud C, Byer K, Nixon CM, Talham DR, 1999. Nucleation of calcium
oxalate monohydrate at phosphilipid monolayers. In: Abstract booklet of 2nd Finlayson
Colloquium on urolithiasis, held Gainesville, Florida, sponsored by ROCK Society; page 20.
37. Peck AB, Thamilselvan S, Cornelius JG, Khan S.R., Sidhu H, 1999, Direct correlation between
hyperoxaluria/ oxalate stone disease and the absence of the GI-dwelling Bacterium Oxalobacter
formigenes: treatment and prevention by gut recolonization and enzyme replacement therapy. In:
Abstract booklet of 2nd Finlayson Colloquium on urolithiasis, held Gainesville, Florida, sponsored
by ROCK Society; page 17.
36. Christmas KG, Khan SR, Gower LA, Adair JA, El-Shall H, 1999, Interaction of Macromolecules
with Calcium Oxalate Monohydrate Crystals in the Presence of Urinary Ions, presented at the
Federation of American Societies for Experimental Biology Research Conference: Calcium Oxalate
in Biological Systems, Denver, Colorado, August, 1999
35. McKee MD, Nanci A, Khan S.R., 1997, Ultrastructural localization of Tamm-Horsfall protein in
human calcium oxalate kidney stones. In: Renal Stone Disease, Crystallization process,
Pathophysiology, Metabolic disorders and Prevention , (P Jungers and M Daudon, eds.) Proc. 7th
European Symposium on Urolithiasis, Paris, France, 124-125.
34. Atmani F, Opalko FJ, Khan S.R., 1997, Cellular membranes present in the urine promote
crystallization of calcium oxalate. In: Renal Stone Disease, Crystallization process, Pathophysiology,
Metabolic disorders and Prevention , (P Jungers and M Daudon, eds.) Proc. 7th European
Symposium on Urolithiasis, Paris, France, 143-144.
32. Thamilselvan S, Hackett R.L., Khan S.R., 1997, Oxalate induced oxidative cellular injury of renal
epithelial cells. In: Renal Stone Disease, Crystallization process, Pathophysiology, Metabolic
disorders and Prevention , (P Jungers and M Daudon, eds.) Proc. 7th European Symposium on
Urolithiasis, Paris, France, 141-142.
54
31. Khan, S.R., 1996, Association between calcium phosphate and calcium oxalate crystals in the
development of urinary stones. In: Mineral Scale Formation and Inhibition, (Z. Amjad, ed.), Plenum
Press, New York, 261-270.
30. Achilles, W., Kroning, M., Schaper, A., and S.R. Khan, 1995. Specific nucleation of spherulitic
calcium phosphate and calcium oxalate crystals in a gel matrix. In: Urolithiasis: Consensus and
Controversies, (P.N. Rao, J.P. Kavanagh and H.-J. Tiselius, eds.) Proc. 5th European Urolithiasis
Symposium, Manchester, England, 275-277.
29. Khan, S.R. and F.J. Opalko, 1995. Constant composition crystallization system. In: Urolithiasis:
Consensus and Controversies, (P.N. Rao, J.P. Kavanagh and H.-J. Tiselius, eds.) Proc. 5th European
Urolithiasis Symposium, Manchester, England, 83-87.
28. Achilles W., and S.R. Khan, 1995. The matrix for in vivo crystal initiation. In: Urolithiasis:
Consensus and Controversies, (P.N. Rao, J.P. Kavanagh and H.-J. Tiselius, eds.) Proc. 5th European
Urolithiasis Symposium, Manchester, England, 5-11.
27. Khan, S.R., R.L. Hackett, 1995. Membranous cellular degradation products as nucleators. In:
Urolithiasis: Consensus and Controversies, (P.N. Rao, J.P. Kavanagh and H.-J. Tiselius, eds.) Proc.
5th European Urolithiasis Symposium, Manchester, England, 13-21.
26. Sindhu, S., K.V. Kurien, K.V., G.N. Subhanna, P. Koshy, S.R. Khan, and Y.M. Fazil Marickar, 1994.
Purity of crystals grown in vitro in the presence of dopants. In: Urolithiasis 2, (R. Ryall, R. Bais, V.R.
Marshall, L.H. Smith and V.R. Walker, eds.,), Plenum Press, New York, 236
25. Cohen, M.C., R. Lobinske and S.R. Khan, 1994. Do bacterial membranes contribute to calcium
oxalate (CaOx) crystal deposition. In: Urolithiasis 2, (R. Ryall, R. Bais, V.R. Marshall, L.H. Smith and
V.R. Walker, eds.,), Plenum Press, New York, 347-349.
24. Adair, J.H., T. Nagira, S.R. Khan, C.M. Brown and W.C. Thomas, 1994. Heterogeneous
deposition of calcium phosphates at the silicon (hydrous) xide-water interface. In: Urolithiasis 2,
(R. Ryall, R. Bais, V.R. Marshall, L.H. Smith and V.R. Walker, eds.,), Plenum Press, New York, 181183.
23. Hackett, R.L., P.N. Shevock and S.R. Khan, 1994. Inhibition of calcium oxalate monohydrate
seed crystal growth is decreased in renal injury. In: Urolithiasis 2, (R. Ryall, R. Bais, V.R. Marshall,
L.H. Smith and V.R. Walker, eds.,), Plenum Press, New York,343-345.
22. Hackett, R.L., P.N. Shevock and S.R. Khan, 1994. Calcium oxalate crystals and ions are injurious
to renal epithelial cells. In: Urolithiasis 2, (R. Ryall, R. Bais, V.R. Marshall, L.H. Smith and V.R.
Walker, eds.,), Plenum Press, New York,325-327.
21. Khan, S.R., C-J Su, P.N. Shevock, and R. L. Hackett, 1994. Beneficial effect of magnesium oxide
55
administration on calcium oxalate urolithiasis. In: Urolithiasis 2, (R. Ryall, R. Bais, V.R. Marshall,
L.H. Smith and V.R. Walker, eds.,), Plenum Press, New York, 657.
20. Khan, S.R., P.N. Shevock, J.D. Sallis and R. L. Hackett, 1994. Phosphocitrate as an inhibitor of
calcium oxalate crystallization in vivo. In: Urolithiasis 2, (R. Ryall, R. Bais, V.R. Marshall, L.H. Smith
and V.R. Walker, eds.,), Plenum Press, New York, 229.
19. Khan, S.R. and R. L. Hackett, 1994. Renal epithelial injury: a risk factor in urolithiasis. In:
Urolithiasis 2, (R. Ryall, R. Bais, V.R. Marshall, L.H. Smith and V.R. Walker, eds.,), Plenum Press,
New York, 29-33.
18. Khan, S.R. and R. L. Hackett, 1994. Role of organic matrix in the formation and growth of
calcium oxalate urinary stones. In: Urolithiasis 2, (R. Ryall, R. Bais, V.R. Marshall, L.H. Smith and
V.R. Walker, eds.,), Plenum Press, New York, 321-323.
17. Khan, S.R. and R.L. Hackett, 1993, Backscattered electron imaging of urinary stone matrix.
Scanning 15, Supplement III: 84-85.
16. Khan, S.R. and R.L. Hackett, 1993, Hyeproxaluria, enzymuria and nephrolithiasis. Contributions
to Nephrology; Kidney, Proteins and Drugs: An Update, (C. Bianchi, V. Bocci, F.A. Carone, R. Rabkin,
eds.) Karger, Basel, Switzerland, 101:190-193.
15. Khan S.R. and L.H. Smith, 1991. Introduction to Proceedings of the Finlayson Colloquium. J. Kid.
Diseases 17, 363.
14. Khan S.R., 1990. Calcification of intrauterine contraceptive devices (IUDs), In: Proceedings of
the XIIth International Congress for Electron Microscopy ,(G.W. Bailey,ed.), San Fransisco Press,
Inc, San Fransisco,
13. Khan S.R. and Hackett R.L., 1989. Membrane-induced calcium oxalate crystal nucleation. In:
Urolithiasis, (V.R. Walker, R.A.L. Sutton, E.C. Bert Cameron, C.L. Pak and W.G. Robertson, eds.)
Plenum Publishing Corporation, New York, 121-123.
12. Khan S.R. and Hackett R.L., 1989. Renal proximal tubular injury and crystallization of calcium
oxalate in rat urine. In: Urolithiasis, (V.R. Walker, R.A.L. Sutton, E.C. Bert Cameron, C.L. Pak and
W.G. Robertson, eds.) Plenum Publishing Corporation, New York, 117-119.
11. Khan S.R., Shevock P.N. and Hackett R.L., 1989. Lipids of calcium oxalate urinary stones. In:
Urolithiasis, (V.R. Walker, R.A.L. Sutton, E.C. Bert Cameron, C.L. Pak and W.G. Robertson, eds.)
Plenum Publishing Corporation, New York, 125-127.
10. Finlayson B., Khan S.R. and Hackett R.L., 1989. Gentamicin accelerates calcium-oxalatemonohydrate (COM) nucleation. In: Urolithiasis, (V.R. Walker, R.A.L. Sutton, E.C. Bert Cameron,
C.L. Pak and W.G. Robertson, eds.) Plenum Publishing Corporation, New York, 59-60.
56
9. Ackermann, D., P. Brown and S.R. Khan, 1989. Preparation and application of calcium oxalate
dihydrate crystal seeds. Urol. Res. 17:147-148.
8. Khan, S.R. 1988. Urinary Stone Analysis, In: Proceedings of the 46th Annual Meeting of the
Electron Microscopy Society of America, (G.W. Bailey,ed.), San Fransisco Press, Inc, San Fransisco,
86-87.
7. Khan, S.R., B. Finlayson and R.L. Hackett, 1985. A microscopic study of the matrix of some
calcium oxalate renal stones, In: Urolithiasis and Related Clinical Research, Proc. Vth
Intl. Symp. Urol. Res. (P.O. Schwille, L.H. Smith, W.G. Robertson and W. Vahlensieck, eds.), Plenum
Publishing Corporation, New York, 923-925.
6. Khan, S.R., B. Finlayson and R.L. Hackett, 1985. Microstructure of calcium oxalate foreign body
stones produced in rat bladder, In: Urolithiasis and Related Clinical Research, Proc. Vth.
Intl. Symp. Urol. Res. (P.O. Schwille, L.H. Smith, W.G. Robertson and W. Vahlensieck, eds.), Plenum
Publishing Corporation New York, 937-940.
5. Newkirk, J.W. and S.R. Khan, 1984. The stability of calcium oxalate during electron irradiation in
an AEM. Proc. 42nd Ann. Meet. Elect. Mirosc. Soc. Am., San Fransisco Press, San Fransisco,
California, 270-171.
4. Khan, S.R., R.L. Hackett, W.C. Thomas, Jr. and B. Finlayson, 1984. Kinetics of calcium oxalate
encrustation on plastic foreign bodies in rat urinary bladders, In: Urinary Calculus, Proc. IInd
Intl. Urin. Stn. Conf., Singapore, (R.L. Ryall, J.G. Brockis, V.R. Marshall and B. Finlayson, eds.),
Churchill Livingstone, N.Y., 363-371.
3.Khan, S.R., B. Finlayson and R.L. Hackett, 1981. Rat renal papillary structure in oxalate
induced microlithiasis, a scanning electron microscopic study, In: Urolithiasis: clinical and basic
research, Proc. IVth Intl. Symp. Urol. Res. (L.H. Smith, W.G. Robertson and B. Finlayson, eds.),
Plenum Publishing Corporation, New York, 517-521.
2. Khan, S.R., B. Finlayson and R.L. Hackett, 1981. The ultrastructure of rat renal tubules in
experimental calcium oxalate nephrolithiasis, In: Urolithiasis: clinical and basic research. Proc. IVth
Intl. Symp. Urol. Res. (L.H. Smith, W.G. Robertson and B. Finlayson, eds.), Plenum Publishing
Corporation, New York, 523-525.
1. Buscemi, P.J., E.P. Golberg, S.R. Khan, R.L. Hackett and B. Finlayson, 1981. Observations on
whewellite stone matrix, In: Urinary Calculus, Proc. Intl. Ur. Stn. Conf. (J.G. Brockis and
B. Finlayson, eds.), P.S.G. Publishing Company Inc., Littleton, Mass., 275-284.
57
MISCELLANEOUS PUBLICATIONS (Abstracts, Letters):
145. Joshi S, Saylor B, Wang W, Peck A, Khan S, 2012, Genome wide analysis of differentially
expressed genes in the kidneys of a rat nephrolithiasis model. J Urol 187: e856-e857
144. Khan S, Glenton P, 2012, Increased urinary excretion of kidney injury molecule (KIM),
osteopontin (OPN), hydrogen peroxide (HP), and monocyte chemoattractant protein-1 (MCP-1), a
good indicator of renal calcioum oxalate (CaOx) crystal deposition and perhaps of stone
formation. J Urol 187: e853
143. Khan, A, Gilani AH, Khan SR, 2011, Expression of Matrix Gla Protein in MDCK cells exposed to
oxalate, calcium oxalate monohydrate and hydroxyapatite crystals. European Urology Supplement
10 (#7): 466
142. Khan S, Khan A, Glenton P, Zuo J, 2011, Effect of apocynin on expression of kidney injury
molecule-1 and calcium oxalate crystal deposition in hyperoxaluric rats. J Urol 185: e820
141. Khan S, Canales B, Monga M, 2011, Formation and growth of Randall’s plaques: an
ultrastructural study of renal papillae from idiopathic stone formers . J Urol 185: e861
140. Canales B, Khan S, 2010, Development of interstitial calcium phosphate deposits in sodium
phosphate co-transporter (npt2a) null mice. J Urol 185: e821
139. Saeed Khan, Benjamin Canales, 2010, Of mice and men: male gender, hyperoxaluria and
hypercalciuria promote calcium oxalate stone formation in mice, J Urol 183: e763
138. Yan Liu, Lan Mo, David Goldfarb, Andrew Evan, Fengxia Liang, Saeed Khan, John Lieske, XueRu Wu, 2010, Ultra-structural study of renal papillary calcinosis in tamm-horsfall protein knockout
mice: relation to randall's plaques in humans, J Urol. 183: e764-e765
137. Benjamin Canales, Saeed Khan, 2010, Resolution of renal papillary injury and Randall's plaque
in a rodent model J Urol 183: e765-e766
136. Khan SR, 2010. Randall's plaque as metastatic calcification in renal papillary interstitium,
evidence from an experimental animal model. Eur Urol Suppl 9(2):166
135. Khan SR and Canales B, 2009, Randal's plaque and papillary injury. Urology 74: S24
134. Canales B, Meguid M, Glenton P, Ryes L, Reinhard M and Khan S, 2009, Renal Histological
Changes after Roux-En-Y gastric bypass surgery in a diet induced obese rat model. Urology 74: S74
133. Khan S and Canales B, 2009, Renal papillary injury and Randall's plaque. Arch It Urol Androl
81: 122-123
58
132. Canales BK, Ryes L, Glenton PA, Chow M, Chen S, Khan SR, 2009, Differential renal tissue
protein profiling in a mouse model of hypercalciuria: effect of high oxalate diet. J Urol 181: 724725
131. Canales BK, Khan SR, Glenton PA, Reyes L, Reinhard MK, Goncalves CG, Meguid MM, 2009,
renal histological changes after RYGB in a diet induced obese rat model. J Urol 181: 721
130. Pattaraporn V, Butterweck V, Khan SR, 2009, Hyperoxaluria is reduced and crystal deposition
prevented by an herbal extract in hyperoxaluric rats. J Urol. 181: 523
129. Khaskhali M H, Khan SR, 2008, Effect of calcium on calcium oxalate crystal induced renal
epithelial injury. J. Urology 179:508
128. Escobar C, Byer KJ, Khan SR, 2007, Biocrystals are less injurious to renal tubular epithelial cells
than the inorganic crystals. European Urology Meetings 2 (1):67
127. Khan SR, 2007, Hypercalciuria and formation of kidney stones. European Urology Meetings 2
(1): 70
126. Venachayangkul P, Byer K, Butterweck V, Khan SR, 2007, Ammi visnaga L. (Khella) extract
prevents cell damage caused by oxalate and calcium oxalate crystals. European Urology Meetings
2 (1):35
125. Daisukho S, Svoronos S, El-Shall H, Rabinovich Y, Byer K, Venachayangkul P, Butterweck V,
Khan SR, 2007, Effect of Khella (Ammi visnaga) extract on kidney stone formation. European
Urology Meetings 2 (1): 97
124. Lawrence L Yeung LL, Johannes W Vieweg JW, Khan SR, Newman RC, Dahm P, 2006, A tribute
to the life and accomplishments of Birdwell Fnlayson. J Urol 177: 354
123. Khan SR, Priola KB, Glenton PA, 2006, Calcium oxalate/calcium phosphate association in
kidney stones. J Urol 177:309
122. Khan SR, 2007, Randall's plaque and renal injury. Kidney Int.71:83
121. Khan SR, Glenton PA, Byer KJ, 2007, Dietary oxalate and calcium oxalate nephrolithiasisresults of an experimental study. Abstracts, Bone, Stone and Kidney, WCN 07 Satellite Synposium,
Rio de Janeiro, Brazil, April 26-28
120. Khan SR, 2006, Re: Dietary oxalate loads and renal oxalate handling. R. P. Holmes, W. T.
Ambrosius and D. G. Assimos, J Urol 175:1576.
119. Umekawa T, Uemura H, Khan SR, 2006, Reactive oxygen species as second messenger for
expression of MCP-1 in NRK52E cell exposed to calcium oxalate monohydrate crystal. JOURNAL OF
59
UROLOGY 175 (4): 336-336
118. Khan SR, Byer KJ, Glenton PA, 2006, Rat model of hydroxy-L-proline induced calcium oxalate
nephrolithiasis. JOURNAL OF UROLOGY 175 (4): 497-497
117. Khan SR.Re, 2006, Dietary oxalate loads and renal oxalate handling R. P. Holmes, WT
Ambrosius and DG Assimos. JOURNAL OF UROLOGY 175 (4): 1576-1576
116. Khan SR, Umekawa T, Iguchi M, Uemura H, 2005, Oxalate ions induce up-regulation of
osteopontin and MCP-1 by renal epithelial cells and interstitial fibroblasts. J Leukocyte Biol 32: 28
Suppl.
115. Khan SR, Habibzadegah-Tari P, 2004, Expression of MCP-1 in HK-2 cells: induction by oxalate
and calcium oxalate crystals and involvement of reactive species. J Am Soc Nephrol 15: 474A
114. Khan S, 2004, Apoptotic changes in renal epithelial cells exposed to oxalate and calcium
oxalate crystals: possible contribution to the development of kidney stones. BJU International 94
(Suppl 2): 98
113. Khan SR, Byer KJ, 2004, Reactive oxygen species as mediators of kidney stone formation,
FASEB JOURNAL 18 (5): A942-A942 Suppl.
112. Khan, SR and Byer KJ, 2004, Citrate provide protection against oxalate and calcium oxalate
crystal induced oxidative damage to renal epithelium. J Urol 171: 296.
111. Delvecchio FC, Brizuela RM, Byer KJ, Springhart WP, Zhong P, Khan SR, Preminger GM,
2004, Citrate and vitamin E blunt the SWL-induced free radical surge in an in vitro MDCK cell
culture model. J Urol 171:295.
110. Umekawa T, Byer KJ, Khan SR, 2004, NADPH oxidase as source of reactive oxygen species in
oxalate and calcium oxalate induced injury of renal epithelial cells. Urol Res 32:145
109. Khan SR, Byer KJ, 2004, Possible protective role for citrate during crystal induced injury.
Urol Res. 32:139
108. Talham DR, Benitez IO, Backov R, Khan SR, 2003, Growth of calcium oxalate monohydrate
at phospholipid monolayers, Abstracts of papers of the American Chemical Society, 225: 277-inor
part 2.
107. Diaz-Diurych CC, Raval AJ, Byer KJ, Khan SR, 2003, Invlvement of calcium phosphate in
idiopathic calcium oxalate nephrolithiasis, Urol Res. 31:75
106. Grewal JS, Tsai JY, Glenton PA, Byer KJ, Khan SR, 2003, Exposure to oxalate and calcium
oxalate crystals induces the expression and production of an immunosuppressive lipocalcin, alpha-
60
1-microglobulin in LLC-PK1 cells via intermediating reactive oxygen species. Urol Res. 31: 76
105. Umekawa T, Chegini N, Khan SR, 2003, Crystal induced expression of MCP-1 in renal
epithelial cells in culture. Urol Res. 31: 77
104. El-Shall H, Jeon JH, Daosukho S, Rabinovich Y, Gower L, Khan S, 2003, Effect of citrate on
nucleation and crystal growth of calcium oxalate monohydrate. Urol Res. 31: 88
103. Rabinovich Y, Esayanur M, Daosukho S, Byer K, El-Shall H, Gower L, Khan S, 2003, Direct
measurement of the interaction force between calcium oxalate monohydrate and biological Cells.
Urol Res. 31: 75
102. Umekawa U, Kurita T, Khan SR, 2003, Angiotensin II receptor blockade prevents calcification
in ethylene glycol treated rats. J Urol 169: 330
101. Khan SR, Glenton PA, Backov R, Talham DR, 2002, Lipids in urine, crystals and stones: do they
have a role in he formation of kidney stones? BJU International 90 (Suppl 2), 257
100. IIDA s, Chikama S, Ishimatsu M, Inoue M, Matsuoka K, Noda S, Khan SR, 2002, Role of heparin
sulfate on cultured epithelial cells during oxalate exposure. BJU International 90 (Suppl 2), 255
99. Grewal JS, Tsai JY, Ghlenton PA, Byer KJ, Khan SR, 2002, Oxalate toxicity induces an
immunosuppressive lipocalin, 1-miroglobulin in LLC-PK eclls via intermediating reactive oxygen
species. J Am Soc Nephrol 13: 492A
98. Hatanaka Y, Umekawa T, Kurita T, Khan SR, 2002, Angiotensin II Type 1 receptor blockade
prevents calcification in ethylene glycol treated rat kidney-relation to kidney inflammation. J Am
Soc Nephrol 13: 576A
97. Khan SR, Glenton PA, Backov R, Talham D, 2002, Presence of lipids in urine, crystals and stones:
implications for the formation of kidney stones. J Am Soc Nephrol 13:388A
96. Thamilselvan S, Hiong X, Khan S, Menon M, 2002, Effect of vitamin E on oxalate induced injury
to renal epithelial cells. J Am Soc Nephrol 13:388A
95. Umekawa T, Kurita T, Khan SR, 2002, Calcium oxalate monohydrate and brushite crystals and
oxalate ions stimulate MCP-1 production in NRK 52 E cells. J Urology 167: 258
94. Khan SR 2002, Inflammation associated with calcium oxalate crystal deposition in the kidneys:
Secretion of chemokines by tubular peithelial cells on exposure to oxalate and calcium oxalate
crystals. Abstracts of 6th European Workshop on Hyperoxaluria, held April 5-6, Hannover,
Germany. Page 25.
93. Umekawa T, Chegini N, Khan SR 2001, Calcium oxalate nephrolithiasis as an inflammatory
61
disease, production of MCP-1 by renal epithelial cells exposed to xoalate and calcium oxalate
crystals. Arch Ital Urol Androlog 73: 61-62.
92. Thamilselvan S, Khan S, Menon M 2001, Effect of vitamin E on cellular antioxidant enzymes
after oxalate exposure to renal culture cells. J Am Soc Nephrol 12: 806A.
91. Umekawa T, Chegini N, Khan SR 2001, Renal epithelial cells produce MCP-1 in culture and its
expression and production is increased by exposure to oxalate ions and calcium oxalate crystals. J
Am Soc Nephrol 12: 759A.
90. Khan SR, Reddy RK, Byer KJ, Glenton PA, 2001, Organic matrix of kidney sones: its location,
composition, and role in stone formation. 1st International Consultation on Stone Disease,
Organized by Am Urol Assoc, Con Am Urol, Eur Assoc Urol, Urol Asssc Asia, Soc Endourol, WHO,
Intl Consul Urol Dis, Intl Soc Urol, Palais des Congress, Paris, France, July 3-4.
89. Khan SR, Backov R, Talham D, 2001, Nucleation of Calcium oxalate at Langmuir monolayers.
Abstracts, Chemcon 2000, Proceedings of the 1st international and 11th National Chemistry
Confetrence, April 10-14, 2001, Peshawar University, Peshawar, Pakistan.
88. Khan SR, Glenton PA, 2001, Does hyperoxaluria induce cytoprotective response by the kidneys.
J Urol, 165(Supplement): 247.
87. Khan SR, Thamilselvan S, 2000, Effect of antioxidants on oxalate induced lipid peroxidation in
renal epithelial cells. J Am Soc Nephrol 11: 609A.
86. Khan SR, Fasano Julie M, 2000, Membrane-mediated crystallization of calcium oxalate in renal
tubules. J Am Soc Nephrol 11: 565A.
85. Khan SR, Thamilselvan S, 2000, Antioxidants; vitamin E, Catalase and superoxide dismutase
protect LLC-PK1 cells from oxalate-induced injury. The 3rd International Symposium on antioxidants and free radicals in health and disease. Vancouver, July 22-25.
84. Maslamani SA, Khan SR, Glenton PA, 2000, Effect of processing on macromolecular
composition of the urine. J Urol 163:231.
83. Thamilselvam S, Khan SR, 2000, Protective effect of vitamin E against oxalate induced free
radical injury to LLC-PK1 cells. J Urol 163:207.
82. Khan SR, Fasano JM, Backov R, Talham DR, 1999, Involvement of cellular membranes and their
lipids in nucleation of stone forming crystals. Abstracts, Materials Research Society, Fall Meeting,
Boston, Nov 29-Dec3. Page 547.
81. Atmani F, Khan SR, 1999, Urinary bikunin as a natural inhibitor of calcium oxalate
crystallization. Arch Ital Urologia Andrologia 121:73.
62
80. Khan SR, 1999, Inhibitors and Promoters of Stone Growth, Abstracts of the 1st Istanbul
Symposium on Urolithiasis, Istanbul, Turkey, page 16.
79. Khan SR, 1999, calcium oxalate crystals are injurious to renal epithelial cells: results of studies
in rat model of hyperoxaluria. Abstracts of the 1st Istanbul Symposium on Urolithiasis, Istanbul,
Turkey, page 18.
78. Moriyama MT, Johnson-Tardieu J, Glenton PA, Khan SR, 1999. Expression of inter-alphainhibitor related proteins in kidneys and urine of hyperoxaluric rats. J Urol 161:249.
77. Thamilselvan S, Byer K, Khan SR, 1999, Antioxidant scavengers protect LLC-PK1 and MDCK cells
from oxalate and calcium oxalate monohydrate crystal- associated cellular injury. J Urol 161:248.
76. Khan SR 1998, Oxalate and calcium oxalate crystals provoke renal epithelial cells: results of
studies in rat model; In: Proceedings of Workshop on New Horizons in the Pathogenesis,
Treatment & Cure of Hyperoxaluria, Oxalosis & Oxalate Stone Diseases; Sponsored by The National
Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH; held December 8-9, 1998,
Bethesda, Maryland, Page 20.
75. Peck Ammon B, Thamilselvan S, Hesse A, Khan S, Sidhu H 1998. Direct correlation between
hyperoxaluria/oxalate stone disease and the absence of the GI-dwelling bacterium, Oxalobacter
formigines: treatment and prevention by the gut recolonization and enzyme-replacement therapy;
In: Proceedings of Workshop on New Horizons in the Pathogenesis, Treatment & Cure of
Hyperoxaluria, Oxalosis & Oxalate Stone Diseases; Sponsored by The National Institute of Diabetes
and Digestive and Kidney Diseases (NIDDK), NIH; held December 8-9, 1998, Bethesda, Maryland,
Page 38.
74. Iida S, Peck AB, Byer K, Johnson-Tardieu J, Glenton PA and Khan SR 1998. Expression of bikunin
mRNA in the renal epithelial cells. J Urol 159: 172.
73. Fasano JM, Khan SR, 1998. Effect of renal tubular brush border membrane on crystallization in
renal tubules. J Urol 159: 172.
72. Johnson-Tardieu J, Glenton P, Byer K, Peck AB and Khan, S.R., 1997. Changes in urinary protein
profiles in an animal model of hyperoxaluria and calcium oxalate nephrolithiasis. J Am Soc Nephrol
8: 563A.
71. Iida S, Johnson-Tardieu J, Glenton P, Byer K, Peck AB and Khan, S.R., 1997. Molecular detection
of bikunin in normal and oxalte exposed kidneys and renal epithelial cells. J Am Soc Nephrol 8:
563A.
70. Atmani F., Opalko F.J. and Khan, S.R., 1997. Membranous substances present in the whole
urine promote calcium oxalate crystallization. J Urol 157: 408.
63
69. Sivagnanan Thamilselvan, Hackett R.L. and Khan S.R., 1997. LLC-PK1 cells are more susceptible
than MDCK cells to oxalate induced oxidative cellular injury. J Urol 157: 19.
68. Atmani F., and Khan, S.R., 1996. Inter-(-inhibitor, another serum protein with potential
involvement in calcium oxalate nephrolithiasis. J Am Soc Nephrol 7: 1798.
67. Thamilselvan S, Hackett R.L. and Khan S.R., 1996. Oxalate toxicity in the kidney and in LLC-PK1
and MDCK cells is mediated by lipid peroxidation. J Am Soc Nephrol 7: 1808.
66. Atmani F., McKee M.D. and Khan, S.R., 1996. Osteopontin in organic matrix of calcium oxalate
crystals and stones. J Urol 155: 642A.
65. Thamilselvan S, Hackett R.L. and Khan S.R., 1996. Lipid peroxidation in experimental
nephrolithiasis. J Urol 155: 642A.
64. Gokhale JA, Khan S.R., 1996. In vivo and in vitro analysis of Tamm-Horsfall protein (THP) from
normal rats and rats with induced nephrolithiasis. J Urol 155: 640A.
63. Atmani F., Khan S.R., 1995. Association of urinary macromolecules with calcium phosphate
crystals induced in human urine. J Am Soc Nephrol 6: 942.
62. Atmani F., Mizon, J., Enghild, J.J. and Khan, S.R., 1995, Uronic acid rich protein and bikunin: a
comparative study. J Bone Min Res 10: S488.
61. Khan, S.R., Glenton P.A., 1995. Urinary excretion of lipids by kidney stone patients. Proceedings
of the VIth European Symposium on Urolithiasis,June 8-10,Stockholm,Sweden. page 49.
60. Gokhale J.A., P.A. Glenton and S.R. Khan, 1995. Study of Tamm-Horsfall Protein (THP) from
normal and nephrolithic rats by in vitro crystal sedimentation assays. Proceedings of the VIth
European Symposium on Urolithiasis, June 8-10, Stockholm, Sweden. page 50.
59. Atmani, F., Mizon J., Khan, S.R., 1995. Comparision of calcium oxalate inhibitory activity of
uronic acid rich protein, inter-(-trypsin inhibitor, and urinary bikunin. Proceedings of the VIth
European Symposium on Urolithiasis, June 8-10, Stockholm, Sweden. page 53.
58. Atmani, F., Opalko, FJ, Khan, S.R., 1995. Incorporation of osteopontin into calcium oxalate
crystals induced in human and rat urine in vitro. Proceedings of the VIth European Symposium on
Urolithiasis, June 8-10, Stockholm, Sweden. page 54.
57. Glenton, P., and Khan, S.R., 1994, Quantifying lipids of the urinary stones. Separations 9:8.
56. McKee, M.D., Nanci, A. and Khan, S.R. 1994. Ultrastructural immunodetection of osteopontin
and osteocalcin as major matrix components of urinary calculi. J. Bone Mineral Res., 9(suppl
1):S379.
64
55. S.R. Khan and P.A. Glenton, 1994. Lipid profile of calcific stone formers urine. Abstracts of 27th
Ann Meeting of Am Soc Nephrol J Am Soc Nephr, p866.
54. Gokhale J.A. P.A. Glenton and S.R. Khan, 1994. Localization of Tamm Horsfall protein and
osteopontin in rat nephrolithiasis model. Abstracts of 27th Ann Meeting of Am Soc Nephrol J Am
Soc Nephr, p863.
53. Fouad Atmani, F. Jeff Opalko and S.R. Khan, 1994. Incorporation of osteopontin into calcium
oxalate crystals induced in normal and stone formers urine. Abstracts of 27th Ann Meeting of Am
Soc Nephrol J Am Soc Nephr, p859.
52. Fouad Atmani and S.R. Khan, 1994. Incorporation of macromolecules into calcium oxalate
crystals induced in rat urine. Abstracts of 27th Ann Meeting of Am Soc Nephrol J Am Soc Nephr,
p859.
51. Fouad Atmani and S.R. Khan, 1994. Characterization of uronic acid rich inhibitor isolated from
rat urine. Abstracts of 27th Ann Meeting of Am Soc Nephrol J Am Soc Nephr, p858.
50. Zhao-Chen Hou and S.R. Khan, 1994. Localization of urinary stone lipids with malachite green.
Proceedings of Florida Society for Microscopy, held May 5-6, 1994, Daytona Beach, Florida, p34.
49. Khan, S.R. and P.A. Glenton, 1994. Association between calcium oxalate and calcium
phosphate crystals in nephrolithiasis. Abstracts of the 89th Annual Meeting of the American
Urological Association, held May 14-29, San Fransisco, J. Urol. 151:425A.
48. Achilles, W., M. Kroning, A. Schaper, S. Khan, and H. Riedmiller, 1994. Specific nucleation by
phospholipids of spherulitic calcium phosphate and calcium oxalate crystals in a gel matrix.
Abstracts of the 5th European Urolithiasis Symposium, held April 21-23, 1994, Manchester,
England, p41.
47. Gokhale, J.A., P.A. Glenton, and S.R. Khan, 1994. Analysis of Tamm Horsfall protein in a rat
model of nephrolithiasis. Abstracts of the 5th European Urolithiasis Symposium, held April 21-23,
1994, Manchester, England, p91.
46. Kok, D.J. and S.R. Khan, Free or fixed particle mechanism. Abstracts of the 5th European
Urolithiasis Symposium, held April 21-23, 1994, Manchester, England, p104.
45. Khan, S.R., P.O. Whalen and P.A. Glenton, 1993. Renal brush border membrane vesicles as
heterogeneous nucleators of calcium oxalate crystals. Abstracts of the 88 Annual Meeting of the
American Urological Association, held May 15-20, San Antonio, J. Urol. 149:440A.
44. Cohen, M.C., R.J. Lobinske, S.R. Khan and P.O. Whalen, 1993. Can Bacterial membranes
contribute to calcium oxalate (CaOx) urolithiasis. Abstracts of the 88 Annual Meeting of the
65
American Urological Association, held May 15-20, San Antonio, J. Urol. 149:440A.
43. Khan, S.R., P.O, Whalen, A. Hevia and P. Glenton, 1993. Cellular membrane as heterogeneous
nucleator of calcium oxalate crystals. Abstracts of the 4th European Symposium on Urolithiasis,
held April 1-3, Tubingen, Germany, Urological Research 21: 156.
42. Gokhale, J.A., P.A. Glenton and S.R. Khan, 1993. Association of Tamm Horsfall Protein with
renal calcium oxalate deposits in rats. Abstracts of the 4th European Symposium on Urolithiasis,
held April 1-3, Tubingen, Germany, Urological Research 21: 155
41. Khan, S.R., J. Adair and R.L. Hackett, 1993. Pathological crystallization of calcium oxalate and
calcium phosphate. Abstracts of the Spring Meeting of the Materials Research Society, page 422,
held April 12-16, San Fransisco.
40. Khan, S.R., J. Finneli, P. Glenton, A. Morrone and J. Adair, 1993. Calcium phosphate deposition
in rat kidneys. Abstracts of the Spring Meeting of the Materials Research Society, page 421, held
April 12-16, San Fransisco.
39. Sindhu, S., K.V. Kurien, K.V., G.N. Subhanna, P. Koshy, S.R. Khan, and Y.M. Fazil Marickar, 1992.
Purity of crystals grown in vitro on adding dopants. Abstracts of the VIIth International Symposium
on Urolithiasis, held August 24-27, Cairns, Australia.
38. Cohen, M.C., R. Lobinske and S.R. Khan, 1992. Do bacterial membranes contribute to calcium
oxalate (CaOx) crystal deposition. Abstracts of the VIIth International Symposium on Urolithiasis,
held August 24-27, Cairns, Australia.
37. Adair, J.H., T. Nagira, S.R. Khan, C.M. Brown and W.C. Thomas, 1992. Heterogeneous
deposition of calcium phosphates at the silicon (hydrous) xide-water interface. Abstracts of the
VIIth International Symposium on Urolithiasis, held August 24-27, Cairns, Australia.
36. Hackett, R.L., P.N. Shevock and S.R. Khan, 1992. Inhibition of calcium oxalate monohydrate
seed crystal growth is decreased in renal injury. Abstracts of the VIIth International Symposium on
Urolithiasis, held August 24-27, Cairns, Australia.
35. Hackett, R.L., P.N. Shevock and S.R. Khan, 1992. Calcium oxalate crystals and ions are injurious
to renal epithelial cells. Abstracts of the VIIth International Symposium on Urolithiasis, held August
24-27, Cairns, Australia.
34. Khan, S.R., C-J Su, P.N. Shevock, and R. L. Hackett, 1992. Beneficial effect of magnesium oxide
administration on calcium oxalate urolithiasis. Abstracts of the VIIth International Symposium on
Urolithiasis, held August 24-27, Cairns, Australia.
33. Khan, S.R., P.N. Shevock, J.D. Sallis and R. L. Hackett, 1992. Phosphocitrate as an inhibitor of
calcium oxalate crystallization in vivo. Abstracts of the VIIth International Symposium on
66
Urolithiasis, held August 24-27, Cairns, Australia.
32. Khan, S.R. and R. L. Hackett, 1992. Renal epithelial injury: a risk factor in urolithiasis. Abstracts
of the VIIth International Symposium on Urolithiasis, held August 24-27, Cairns, Australia.
31. Khan, S.R. and R. L. Hackett, 1992. Role of organic matrix in the formation and growth of
calcium oxalate urinary stones. Abstracts of the VIIth International Symposium on Urolithiasis, held
August 24-27, Cairns, Australia.
30. Mehta, Jawahar L., Nicolini, F.A., Nicholas, W.W., Khan, S.R. and T.G.P. Saldeen, 1992. Coronary
artery narrowing distal to the thrombus after thrombolysis: Primary vasospasm or platelet
activation. J. American College of Cardiology 19: 322A.
29. Nicolini, F.A., Nicholas, W.W., Saldeen, T.G.P., Khan, S.R. and J.L. Mehta, 1992. Adjunctive
therapy with low molecular weight heparin with t-PA causes sustained reflow, but reperfused
coronary arteries show residual thrombus. Proceedings of XIV Interamerican Congress of
Cardiology, held May 23-27, Orlando.
28. Khan, S.R. and James C. Woodard, 1992. Structure of kidney stone removed from south
american maned wolf. Proceedings of the 10th anniversary meeting of Florida Society for Electron
Microscopy. page 14.
27. Khan, S.R., Su, C.J., Shevock, P.N. and R.L. Hackett, 1992. Magnesium oxide administration and
experimental calcium oxalate urolithiasis. J. Urol. 147: page 331A.
26. Khan, S.R., and R.L. Hackett, 1991. Hyperoxaluria, enzymuria and nephrolithiasis. In: Abstracts
of the VIIth International Symposium at Montecatini; Kidney, Proteins and Drugs, Held
Montecatini Terme, Italy Oct. 14-16, page 22.
25. Khan, S.R., Su, C.J., Shevock, P.N. and R.L. Hackett, 1991. Effect of Magnesium oxide on calcium
oxalate urolithiasis. J. Urol.
24. Normann, S., D. Saloman, P. Leelachaikul, S. Khan, E. Staples, J. Alexander, W. Mayfield, D.
Knauf, L. Sadler, and S. Selman, 1991. Acute coronary artery rejection following heart
transplantation. J. Heart and Lung Transpl., 10: page 192.
23. Khan, S.R. 1991. Backscattered imaging of plastic embedded decalcified human calcium oxalate
dihydrate urinary stone. Proc. 26th Ann. S.E.E.M.S. Meeting, page 37.
22. Khan, S.R., P.N. Shevock, and R.L. Hackett, 1991. Renal injury and urinary excretion of enzymes
after intraperitoneal administration of sodium oxalate. The FASEB Journal 5 (6): A1615.
21. Gokhale J.A. and S.R. Khan, 1990. Ultrastructure of microwave fixed rat kidneys. J. Electr.
Microsc. Tech. 15: 418.
67
20. Khan, S.R., 1990. Ultrastructure of calcified IUDs. J. Elect. Micr. Tech. 15: 419.
19. Khan, S.R. and E.J. Wilkinson, 1989. Calcified intrauterine device as a bladder stone. J. Electr.
Microsc. Tech. 13, 374.
18. Khan, S.R. and R.L. Hackett, 1989. Urinary enzymes in calcium oxalate urolithiasis. J.Urol. 141,
452A.
17. Khan, S.R. and R.L. Hackett, 1989. Hyperoxaluria and calcium oxalate relative supersaturation.
J.Urol. 141, 452A.
16. Senior, D.F., J.M. Gaskin, C.D. Buergelt, S.R. Khan, D.A. Sundstrom, 1989. Effect of oral
pentosan polysulfate and ovariohysterectomy on the clearance of experimentally induced
bacterial cystitis in dogs. J. Urol. 141, 364A.
15. Khan, S.R. 1988. Struvite crystals in aseptic rat urine. Proceedings of the VIth annual meeting of
the Florida Society for Electron Microscopy.
14. Khan, S.R. and R.L. Hackett, 1987. Lipids of human urinary stones. XX European Symposium on
Calcified Tisssues, Sirmione, Italy, Calcified Tissue International 41, Supplement 2, p 63.
13. Khan, S.R. and R.L. Hackett, 1987. In vitro crystallization of calcium oxalate mediated by lipids
of urinary stone matrix. XX European symposium on calcified tissues, Sirmione, Italy, Calcified
Tissue International 41, Supplement 2, p 21.
12. Khan, S.R. and R.L. Hackett, 1987. Role of calcium oxalate crystal morphology in classification
of Zygomyceters. 52nd Annual Meeting of the Mycological Society of America, Ottawa, Canada.
11. Khan, S.R. and R.L. Hackett, 1987. X-ray microanalysis for identification of foreign material in
pathology specimens. Proceedings of the Vth Annual meeting of Florida Society for Electron
Microscopy. p 26.
10. Khan, S.R. and R.L. Hackett, 1985. Concentric laminations in rat bladder foreign body stones: an
SEM study. Proceedings of the IIIrd Annual Meeting of Florida Society for Electron Microscopy. p 7.
9. Newkirk, J.W. and S.R. Khan, 1984. The stability of calcium oxalate during electron irradiation in
an AEM. Proc. of 2nd Annual Meeting of Florida Soc. Electr. Microsc.
8. Khan, S.R., B. Finlayson and R.L. Hackett, 1984. A microscopic study of the matrix of some
calcium oxalate renal stones. Abstract, Vth Intl. Symp. Urol. Res., Garmisch, W. Germany,
Urol. Res. 12, 92.
7. Khan, S.R., B. Finlayson and R.L. Hackett, 1984. Microstructure of calcium oxalate foreign body
68
stones. Abstract, Vth Intl. Symp. Urol. Res., Garmisch, W. Germany, Urol. Res. 12, 54.
6. Hackett, R.L. and S.R. Khan, 1984, Letter to the editor, Re: Increased urinary excretion of renal
enzymes in idiopathic calcium oxalate nephrolithiasis. J. Urol. 131, 125.
5. Khan, S.R., R.L. Hackett and B. Finlayson, 1983. An experimental model for crystalluria. Abstract,
Proc. IInd Nat. Conf. Urol. Soc. India, Trivandrum, India, 133.
4. Khan, S.R. 1983. Structure of bladder stones seen by electron microscopy. An interview
published in Urology Times. 11, 16.
3. Khan, S.R., B. Finlayson and R.L. Hackett, 1982. Induction of rat bladder stones using plastic
discs as foreign bodies. Presented at XIX Cong. Soc. Intl. Urol., San Francisco.
2. Finlayson, B., S.R. Khan and R.L. Hackett, 1982. Micropore structure of calcium oxalate
stones. Presented at XIX Cong. Soc. Intl. Urol., San Francisco.
1. Khan, S.R. 1976. Electron microscopy as an aid in fungal taxonomy. Supplement to
Aust. Pl. Pathol. Soc. Newslet. 5, 46.
69